<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for the treatment of metastatic extradural spinal cord compression in adults - George, R - 2015 | Cochrane Library</title> <meta content="Interventions for the treatment of metastatic extradural spinal cord compression in adults - George, R - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006716.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for the treatment of metastatic extradural spinal cord compression in adults - George, R - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006716.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006716.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for the treatment of metastatic extradural spinal cord compression in adults" name="citation_title"/> <meta content="Reena George" name="citation_author"/> <meta content="Christian Medical College" name="citation_author_institution"/> <meta content="reena.vellore@gmail.com" name="citation_author_email"/> <meta content="Jenifer Jeba Sundararaj" name="citation_author"/> <meta content="Christian Medical College" name="citation_author_institution"/> <meta content="Ramkumar Govindaraj" name="citation_author"/> <meta content="Royal Adelaide Hospital" name="citation_author_institution"/> <meta content="Ari G Chacko" name="citation_author"/> <meta content="Christian Medical College" name="citation_author_institution"/> <meta content="Prathap Tharyan" name="citation_author"/> <meta content="Christian Medical College" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD006716.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/09/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006716.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006716.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006716.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Decompression, Surgical; Adrenal Cortex Hormones [*therapeutic use]; Analgesics [administration &amp; dosage]; Combined Modality Therapy [methods]; Laminectomy; Narcotics [administration &amp; dosage]; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Spinal Cord Compression [etiology, *therapy]; Spinal Neoplasms [secondary, *therapy]; Walking" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006716.pub3&amp;doi=10.1002/14651858.CD006716.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ytRBD0EW";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006716\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006716\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006716.pub3",title:"Interventions for the treatment of metastatic extradural spinal cord compression in adults",firstPublishedDate:"Sep 4, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pain, Palliative and Supportive Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ytRBD0EW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006716.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006716.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006716.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006716.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006716.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006716.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006716.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006716.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006716.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006716.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4141 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006716.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-sec-0154"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-sec-0032"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-sec-0033"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-sec-0074"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-sec-0137"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/appendices#CD006716-sec-0163"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/table_n/CD006716StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/table_n/CD006716StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for the treatment of metastatic extradural spinal cord compression in adults </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information#CD006716-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Reena George</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information#CD006716-cr-0003">Jenifer Jeba Sundararaj</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information#CD006716-cr-0004">Ramkumar Govindaraj</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information#CD006716-cr-0005">Ari G Chacko</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information#CD006716-cr-0006">Prathap Tharyan</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information/en#CD006716-sec-0169">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 September 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006716.pub3">https://doi.org/10.1002/14651858.CD006716.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006716-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006716-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006716-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006716-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006716-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006716-abs-0001" lang="en"> <section id="CD006716-sec-0001"> <h3 class="title" id="CD006716-sec-0001">Background</h3> <p>Metastatic extradural spinal cord compression (MESCC) is treated with radiotherapy, corticosteroids, and surgery, but there is uncertainty regarding their comparative effects. This is an updated version of the original Cochrane review published in the<i>Cochrane Database of Systematic Reviews</i> (Issue 4, 2008). </p> </section> <section id="CD006716-sec-0002"> <h3 class="title" id="CD006716-sec-0002">Objectives</h3> <p>To determine the efficacy and safety of radiotherapy, surgery and corticosteroids in MESCC. </p> </section> <section id="CD006716-sec-0003"> <h3 class="title" id="CD006716-sec-0003">Search methods</h3> <p>In March 2015, we updated previous searches (July 2008 and December 2013) of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, LILACS, CANCERLIT, clinical trials registries, conference proceedings, and references, without language restrictions. We also contacted experts for relevant published, unpublished and ongoing trials. </p> </section> <section id="CD006716-sec-0004"> <h3 class="title" id="CD006716-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) of radiotherapy, surgery and corticosteroids in adults with MESCC. </p> </section> <section id="CD006716-sec-0005"> <h3 class="title" id="CD006716-sec-0005">Data collection and analysis</h3> <p>Three authors independently screened and selected trials, assessed risk of bias, and extracted data. We sought clarifications from trial authors. Where possible, we pooled relative risks with their 95% confidence intervals, using a random effects model if heterogeneity was significant. We assessed overall evidence‐quality using the GRADE approach. </p> </section> <section id="CD006716-sec-0006"> <h3 class="title" id="CD006716-sec-0006">Main results</h3> <p>This update includes seven trials involving 876 (723 evaluable) adult participants (19 to 87 years) in high‐income countries. Most were free of the risk of bias. </p> <p>Different radiotherapy doses and schedules </p> <p>Two equivalence trials in people with MESCC and a poor prognosis evaluated different radiotherapy doses and schedules. In one, a single dose (8 Gray (Gy)) of radiotherapy (RT) was as effective as short‐course RT (16 Gy in two fractions over one week) in enhancing ambulation in the short term (65% versus 69%; risk ratio (RR) was 0.93, (95% confidence interval (CI) 0.82 to 1.04); 303 participants; <i>moderate quality evidence</i> ). The regimens were also equally effective in reducing analgesic and narcotic use (34% versus 40%; RR 0.85, 95% CI 0.62 to 1.16; 271 participants), and in maintaining urinary continence (90% versus 87%; RR 1.03, 95% CI 0.96 to 1.1; 303 participants) in the short term (<i>moderate quality evidence</i> ). In the other trial, split‐course RT (30 Gy in eight fractions over two weeks) was no different from short‐course RT in enhancing ambulation (70% versus 68%; RR 1.02, 95% CI 0.9 to 1.15; 276 participants); reducing analgesic and narcotic use (49% versus 38%; RR 1.27, 95% CI 0.96 to 1.67; 262 participants); and in maintaining urinary continence (87% versus 90%; RR 0.97, 0.93 to 1.02; 275 participants) in the short term (<i>moderate quality evidence</i> ). Median survival was similar with the three RT regimens (four months). Local tumour recurrence may be more common with single‐dose compared to short‐course RT (6% versus 3%; RR 2.21, 95% CI 0.69 to 7.01; 303 participants) and with short‐course compared to split‐course RT (4% versus 0%; RR 0.1, 95% CI 0.01 to 1.72; 276 participants), but these differences were not statistically significant (<i>low quality evidence</i> ). Gastrointestinal adverse effects were infrequent with the three RT regimens (<i>moderate quality evidence</i>), and serious adverse events or post‐radiotherapy myelopathy were not noted. </p> <p>We did not find trials comparing radiotherapy schedules in people with MESCC and a good prognosis. </p> <p>Surgery plus radiotherapy compared to radiotherapy </p> <p>Laminectomy plus RT offered no advantage over RT in one small trial with 29 participants (<i>very low quality evidence</i> ). In another trial that was stopped early for apparent benefit, decompressive surgery plus RT resulted in better ambulatory rates (84% versus 57%; RR 1.48, 95% CI 1.16 to 1.90; 101 participants, <i>low quality evidence</i> ). Narcotic use may also be lower, and bladder control may also be maintained longer than with than RT in selected patients (<i>low quality evidence</i> ). Median survival was longer after surgery (126 days versus 100 days), but the proportions surviving at one month (94% versus 86%; RR 1.09, 95% CI 0.96 to 1.24; 101 participants) did not differ significantly (<i>low quality evidence).</i> Serious adverse events were not noted. Significant benefits with surgery occurred only in people younger than 65 years. </p> <p>High dose corticosteroids compared to moderate dose or no corticosteroids </p> <p>Data from three small trials suggest that high‐dose steroids may not differ from moderate‐dose or no corticosteroids in enhancing ambulation (60% versus 55%; RR 1.08, 95% CI 0.81 to 1.45; 3 RCTs, 105 participants); survival over two years (11% versus 10%; RR 1.11, 95% CI 0.24 to 5.05; 1 RCT, 57 participants); pain reduction (78% versus 91%; RR 0.86, 95% CI 0.62 to 1.20; 1 RCT, 25 participants); or urinary continence (63% versus 53%; RR 1.18, 95% CI 0.66 to 2.13; 1 RCT, 34 participants; <i>low quality evidence</i> ). Serious adverse effects were more frequent with high‐dose corticosteroids (17% versus 0%; RR 8.02, 95% CI 1.03 to 62.37; 2 RCTs, 77 participants; <i>moderate quality evidence</i>). </p> <p>None of the trials reported satisfaction with care or quality of life in participants.</p> </section> <section id="CD006716-sec-0007"> <h3 class="title" id="CD006716-sec-0007">Authors' conclusions</h3> <p>Based on current evidence, ambulant adults with MESCC with stable spines and predicted survival of less than six months will probably benefit as much from one dose of radiation (8 Gy) as from two doses (16 Gy) or eight doses (30 Gy). We are unsure if a single dose is as effective as two or more doses in preventing local tumour recurrence. Laminectomy preceding radiotherapy may offer no benefits over radiotherapy alone. Decompressive surgery followed by radiotherapy may benefit ambulant and non‐ambulant adults younger than 65 years of age, with poor prognostic factors for radiotherapy, a single area of compression, paraplegia for less than 48 hours, and a predicted survival of more than six months. We are uncertain whether high doses of corticosteroids offer any benefits over moderate doses or indeed no corticosteroids; but high‐dose steroids probably significantly increases the risk of serious adverse effects. Early detection; and treatment based on neurological status, age and estimated survival, are crucial with all treatment modalities. Most of the evidence was of low quality. High‐quality evidence from more trials is needed to clarify current uncertainties, and some studies are in progress. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006716-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006716-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006716-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006716-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006716-abs-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006716-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006716-abs-0002" lang="en"> <h3>Interventions for the treatment of spinal cord compression due to the spread of cancer</h3> <p>Metastatic extradural spinal cord compression (MESCC) due to cancer from other parts of the body affecting the spine and causing compression of the spinal cord often results in pain, impaired functioning including reduced ability to walk, incontinence, and shortened survival. Radiation is the mainstay of treatment, but surgery, and corticosteroids are also used to treat people with MESCC. This update of a previous review published in 2008 evaluates the clinical trial evidence up to 3 March 2015 to determine how effective radiotherapy, surgery and corticosteroids are in improving functioning and survival, and in reducing pain; and how well tolerated they are in adults with MESCC. </p> <p>We found seven studies conducted in high‐income countries including 876 adults (aged 19 to 87 years) with MESCC. Follow‐up ranged from one month to three years, and the number evaluated in each varied from 29 to 303. Two studies compared different doses of radiation, two compared surgery before radiation versus radiation alone, and three small trials evaluated the effects of high‐dose corticosteroids versus moderate‐dose steroids or placebo. </p> <p>The key results are: 1. For different doses of radiation: one dose of radiation was as effective as two doses and two doses were as effective as eight doses of radiation in adults with spinal cord compression with stable spines who are expected to live for less than six months. Adults with a better prognosis may require the longer radiation course to prevent local cancer recurrence, but the immediate benefits of shorter courses might be important for people with MESCC who have only a short time to live. No serious adverse events were noted, and the incidence of diarrhoea, nausea and vomiting was low and no different with the different radiation doses. 2. For surgery before radiation: removing part of the vertebra to enlarge the spinal canal (laminectomy) before radiation offered no advantages over radiation alone. Direct decompressive surgery (directly accessing and removing affected parts of the vertebrae and, if required, fixing the spines using bone grafts and instruments) followed by radiation treatment was more effective than radiation alone in carefully selected adults younger than 65 years. Surgery plus radiation did not cause more harmful effects than radiation alone. 3. For high dose steroids: beneficial effects were not significantly different with high‐dose versus moderate‐dose steroids or placebo, but serious adverse effects were more frequent with high‐dose steroids. </p> <p>None of the studies reported on satisfaction with care or quality of life. We also did not find trials comparing different radiation doses in adults with MESCC with a good prognosis. We lacked full confidence in many results since they came from single trials or a few small trials. Also, in the study of decompressive surgery, some of the adults given radiation alone had cancers that were only moderately sensitive to radiation, and a third of patients in both intervention arms had unstable spines. In usual clinical practice, surgery, not radiation, is the preferred option in such instances. The overall GRADE quality of evidence was <i>moderate</i> for all outcomes for the comparisons of different radiation doses and for the adverse effects of high doses of corticosteroids, indicating reasonable confidence in the results, though future research could alter the estimates in this review and our confidence in the estimates. The GRADE quality of evidence was <i>very low</i> for all outcomes in the comparison of laminectomy, and <i>low</i> for the outcome of local tumour recurrence with different radiation doses, for all outcomes in the comparison with decompressive surgery, and for the efficacy outcomes in the comparison of high‐dose corticosteroids. This indicates less confidence in these results, and acknowledges that future research is likely to alter the estimates in this review. More studies are required to clarify these uncertainties and some are in progress. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006716-sec-0154" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006716-sec-0154"></div> <h3 class="title" id="CD006716-sec-0155">Implications for practice</h3> <section id="CD006716-sec-0155"> <section id="CD006716-sec-0156"> <h5 class="title">General implications</h5> <p>Early detection and institution of treatment are crucial. Patients and clinicians should be educated about the symptoms of spinal cord compression, and patients should ideally be assessed by a multidisciplinary team, with treatment decisions taking into account the neurologic status, age and estimated survival. Prognostic scores for survival and spinal instability are available. </p> </section> <section id="CD006716-sec-0157"> <h5 class="title">Radiotherapy</h5> <p> <ul id="CD006716-list-0014"> <li> <p>Radiotherapy is an essential component of treatment in adults with MESCC. Radiotherapy could be considered as the primary treatment for ambulant people with MESCC and stable spines and for those who do not meet the criteria for decompressive surgery listed below. </p> </li> <li> <p>Short courses of radiotherapy (one to two fractions) could be considered for people with MESCC with a predicted survival of less than three to six months, particularly if they are ambulant, and have radio‐sensitive tumours. Evidence from this review indicates that non‐ambulant patients have only a 16% chance of regaining ambulation with a single dose of radiotherapy and 29% with short courses of radiotherapy. </p> </li> <li> <p>Since short courses of radiotherapy (8 Gy to 16 Gy in one or two fractions) may be associated with a higher risk of local recurrence than longer courses (8 fractions; 30 Gy) or more, patients with a good prognosis could be considered for longer courses of radiotherapy. In people with MESCC who only have a short time to live, the benefits with the shorter courses may be important. </p> </li> <li> <p>The optimum dose and fractionation for RT in people with MESCC who have a good prognosis is currently uncertain. </p> </li> <li> <p>Since the overall GRADE quality of evidence for the efficacy and safety outcomes with different radiation doses was only of <i>moderate quality</i> (and <i>low quality</i> for local recurrence), it is possible that future research may impact on our confidence in the estimates of effect, and alter these estimates and the implications for practice. </p> </li> </ul> </p> </section> <section id="CD006716-sec-0158"> <h5 class="title">Decompressive surgery</h5> <p> <ul id="CD006716-list-0015"> <li> <p>Decompressive surgery could be considered in people younger than 65 years with MESCC, who are fit to undergo surgery, have lost motor function for less than 48 hours, have localised cord compression, unfavourable histologies, and an estimated survival of greater than three months. </p> </li> <li> <p>Decompressive surgery could also be considered in ambulant patients with poor prognostic factors for radiotherapy (e.g. spinal instability, bony compression, rapidly progressive neurologic deficits, tumours not sensitive to radiation), provided good prognostic factors for survival are present. </p> </li> <li> <p>Decompressive surgery should ideally be followed immediately by postoperative radiotherapy for optimal ambulatory and survival outcomes. Postoperative RT was instituted within two weeks after surgery in the trial in this review and the evidence from another observational study also indicates that optimal outcomes with decompressive surgery depend on RT being given within two weeks of decompressive surgery (<a href="./references#CD006716-bbs2-0058" title="RadesD , HuttenlocherS , BajrovicA , KarstensJH , AdamietzIA , KazicN , et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. International Journal of Radiation Oncology, Biology, Physics2011;81(5):e861‐8. ">Rades 2011b</a>). The optimal fractionation schedules and dose for postoperative RT are uncertain. </p> </li> <li> <p>Since the overall GRADE quality of evidence for all outcomes with decompressive surgery was of <i>low quality</i>, it is likely that future research could affect the implications for practice. </p> </li> </ul> </p> </section> <section id="CD006716-sec-0159"> <h5 class="title">Corticosteroids</h5> <p> <ul id="CD006716-list-0016"> <li> <p>High doses of corticosteroids (96 mg to 100 mg dexamethasone) carry a significant risk of serious adverse effects. </p> </li> <li> <p>It is uncertain if they offer any additional benefit over moderate doses of steroids (16 mg to 32 mg of dexamethasone) or no steroids. </p> </li> <li> <p>The optimal dose and duration of corticosteroid treatment to be given with radiation or decompressive surgery is currently unclear. </p> </li> <li> <p>The overall GRADE quality of evidence was <i>moderate</i> for the risk of serious adverse effects and <i>low</i> for all other outcomes; hence it is possible that future research may affect the implications for practice. </p> </li> </ul> </p> </section> </section> <h3 class="title" id="CD006716-sec-0160">Implications for research</h3> <section id="CD006716-sec-0160"> <p>The two ongoing trials (<a href="./references#CD006716-bbs2-0017" title="A randomised feasibility study of single fraction radiotherapy compared to multi‐fraction radiotherapy in patients with metastatic spinal cord compression. http://controlled‐trials.com, UK Clinical Trials Gateway. [CRUK‐UCL‐BRD‐07‐010; EU‐20863; NCT00727584] ">ISRCTN97555949</a>; <a href="./references#CD006716-bbs2-0018" title="A randomised phase III trial of two fractionation schemes in the treatment of malignant spinal cord compression (Spinal Cord Compression. ICORG 05‐03, V6). http://clinicaltrials.gov/show/NCT00968643. [CDR0000644307; EU‐20952; ICORG‐05‐03] ">NCT00968643</a>), when completed and reported, will provide more data to help clarify the effects of different short RT regimens in people with MESCC not selected for having a poor prognosis. The first, being conducted in the UK, is comparing a single fraction of 8 Gy to 20 Gy in five fractions (<a href="./references#CD006716-bbs2-0017" title="A randomised feasibility study of single fraction radiotherapy compared to multi‐fraction radiotherapy in patients with metastatic spinal cord compression. http://controlled‐trials.com, UK Clinical Trials Gateway. [CRUK‐UCL‐BRD‐07‐010; EU‐20863; NCT00727584] ">ISRCTN97555949</a>; SCORAD). The second, underway in Ireland, is comparing a single fraction of 10 Gy to 20 Gy in five fractions (<a href="./references#CD006716-bbs2-0018" title="A randomised phase III trial of two fractionation schemes in the treatment of malignant spinal cord compression (Spinal Cord Compression. ICORG 05‐03, V6). http://clinicaltrials.gov/show/NCT00968643. [CDR0000644307; EU‐20952; ICORG‐05‐03] ">NCT00968643</a>; IRCOG). </p> <p>Adequately powered, multinational RCTs are needed to:</p> <p> <ul id="CD006716-list-0017"> <li> <p>define appropriate radiotherapy schedules for good‐prognosis patients with MESCC (if deemed necessary after the results of the ongoing trials are included in an update of this review); </p> </li> <li> <p>clarify the role of decompressive surgery in different prognostic groups and health care settings; </p> </li> <li> <p>determine the optimal radiotherapy dose and fractionation regimens after surgical interventions; </p> </li> <li> <p>determine the optimal dosage and duration of corticosteroids. (If future studies comparing different doses of corticosteroids are conducted, they should be adequately powered to ascertain the balance between benefits and adverse effects with different doses of corticosteroids, but should also optimally select patients for their suitability for RT or decompressive surgical interventions as the primary treatment modalities); </p> </li> <li> <p>determine the efficacy and safety of minimally invasive surgical techniques, intensity modulated RT, and radiosurgery in the primary treatment of MESCC; and in those with local recurrences. </p> </li> </ul> </p> <p>Trials should report results in accordance with the <a href="./references#CD006716-bbs2-0023" title="SchulzKF , AltmanDG , MoherD , CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Medicine2010;7(3):e1000251. ">CONSORT 2010</a> guidelines. Various prognostic scales are currently available; and stratification by prognostic factors is important in future RCTs comparing different interventions. These trials would need to be adequately powered to detect differences between subgroups. Where appropriate, outcomes and endpoints should be patient‐ and caregiver‐defined. </p> <p>Additionally, there is need for both qualitative and quantitative research into education, rehabilitation, screening and supportive care for patients with MESCC. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006716-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006716-sec-0022"></div> <div class="table" id="CD006716-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Single‐fraction radiotherapy (8 Gy) compared to short‐course radiotherapy (16 Gy in two fractions) for adults with metastatic extradural spinal cord compression</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Single‐fraction radiotherapy (8 Gy) compared to short‐course radiotherapy (8 Gy ‐ two fractions over one week) for adults with metastatic extradural spinal cord compression</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with metastatic extradural spinal cord compression (poor prognosis with visceral metastasis, and no spinal instability or bony impingement of cord)<br/> <b>Intervention:</b> single‐fraction (8 Gy) radiotherapy<br/> <b>Comparison:</b> short‐course (8 Gy ‐ two fractions over one week) radiotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Short‐course radiotherapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Single‐fraction radiotherapy </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ambulation</b> </p> <p>One month after radiation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>693 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>645 per 1000</b><br/> (569 to 721) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.93</b> <br/> (0.82 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303<br/> (1 study<sup>1</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single‐fraction and short‐course radiotherapy are probably equally effective in enhancing ambulation (maintaining and regaining ambulation) in the short term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival</b><br/> Follow‐up: mean 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median survival was similar with both radiotherapy schedules (four months).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in analgesic and narcotic use</b> </p> <p>One month after radiation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>403 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>343 per 1000</b><br/> (250 to 467) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.85</b> <br/> (0.62 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>271<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single‐fraction and short‐course radiotherapy are probably equally effective in reducing analgesic and narcotic use in the short term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary continence</b> </p> <p>One month after radiation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>873 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>900 per 1000</b><br/> (838 to 961) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.03</b> <br/> (0.96 to 1.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single‐fraction and short‐course radiotherapy are probably equally effective in enhancing urinary continence overall, and in the proportions maintaining or regaining continence one month after treatment. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Local recurrence</b><br/> MRI: follow‐up: median 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>59 per 1000</b><br/> (18 to 187) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.21</b> <br/> (0.69 to 7.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,4</sup> </p> <p>(serious indirectness, serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Short‐course radiotherapy may result in fewer local recurrences than single fraction radiotherapy, but the numbers with local recurrences were too few for the difference to be statistically significant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b><br/> Grade 3 oesophagitis, diarrhoea and nausea </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b><br/> (0 to 54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.14</b> <br/> (0.01 to 2.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single‐fraction and short‐course radiotherapy probably do not differ significantly in the incidence of gastrointestinal adverse effects. Serious adverse events or post‐radiotherapy myelopathy were not noted with either treatment schedule. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup><a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> was conducted in multiple sites in Italy and used an equivalence design with the sample size powered to demonstrate equivalence in response rates separately evaluated for ambulatory status (maintaining or regaining ambulation), urinary continence (not requiring a catheter), and reduction in back pain (not requiring a narcotic) one month after treatment. Parenteral dexamethasone (8 mg twice daily) was administered from the first day of clinical‐radiologic diagnosis for 4–5 days.<br/> <sup>2</sup> Serious indirectness: the trial included those usually given short‐course radiotherapy (those with poor prognosis, with visceral metastasis, and not suitable for surgery). However the evidence for the equivalence of single dose and short‐course radiotherapy is from only one trial from a high‐income country, where early diagnosis and early institution of radiotherapy (within 24 to 48 hours after diagnosis) was possible; these may not be possible in many resource constrained settings. Downgraded 1 level.<br/> <sup>3</sup> No imprecision: the trial was powered to demonstrate equivalence in response rates post‐treatment and the difference in response rates with the two radiotherapy schedules was within the pre‐set precision limits. Not downgraded.<br/> <sup>4</sup> Serious imprecision: the trial was not powered to detect equivalence for this outcome; the 95% CI of the effect estimate includes no difference. The number of events were few and the sample size was smaller than the optimal sample size. Downgraded 1 level. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006716-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Split‐course radiotherapy (8 fractions, 30 Gy) compared to short‐course radiotherapy (2 fractions, 16 Gy) for adults with metastatic extradural spinal cord compression</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Split‐course (8 fractions, 30 Gy) radiotherapy compared to short‐course (2 fractions, 16 Gy) radiotherapy for adults with metastatic extradural spinal cord compression</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with metastatic extradural spinal cord compression (poor prognosis, no spinal instability or bony impingement of cord)<br/> <b>Intervention:</b> split‐course radiotherapy (8 fractions‐ 5 Gy × 3; 3 Gy × 5 = 30 Gy)<br/> <b>Comparison:</b> short‐course radiotherapy (2 fractions × 8 Gy = 16 Gy) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Short‐course radiotherapy (2 fractions)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Split‐course radiotherapy (8 fractions)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ambulation</b> <br/> One month after treatment </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>683 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>697 per 1000</b><br/> (615 to 786) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.02</b> <br/> (0.9 to 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>276<br/> (1 study<sup>1</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Split‐course and short‐course radiotherapy are probably equally effective in enhancing ambulation (maintaining and regaining ambulation) in the short term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival</b><br/> Follow‐up: median 33 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median survival was similar with both treatment schedules (four months).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in analgesic and narcotic use</b> </p> <p>One month after radiation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>382 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>486 per 1000</b><br/> (367 to 639) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.27</b> <br/> (0.96 to 1.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>262<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Split‐course and short‐course radiotherapy are probably equally effective in reducing analgesic and narcotic use in the short term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary continence</b> </p> <p>One month after radiation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>901 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>874 per 1000</b><br/> (838 to 919) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> <br/> (0.93 to 1.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>275<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Split‐course and short‐course radiotherapy are probably equally effective in enhancing urinary continence overall, and in the proportions maintaining or regaining continence one month after treatment. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Local recurrence</b><br/> Follow‐up: median 33 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>35 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 1000</b><br/> (0 to 61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.1</b> <br/> (0.01 to 1.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>276<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,4</sup> </p> <p>(serious indirectness, serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Split‐course radiotherapy probably results in fewer local recurrences than short‐course radiotherapy, but the numbers with local recurrences were too few to demonstrate statistically significant differences. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b><br/> Grade 3 oesophagitis, diarrhoea, and nausea </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>21 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b><br/> (9 to 153) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.77</b> <br/> (0.43 to 7.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>276<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Split‐course and short‐course radiotherapy probably do not differ significantly in the incidence of gastrointestinal adverse effects. Serious adverse events or post‐radiotherapy myelopathy were not noted with either treatment schedule. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup><a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> was conducted in multiple sites in Italy and used an equivalence design with the sample size powered to demonstrate equivalence in response rates separately evaluated for ambulatory status (maintaining or regaining ambulation), urinary continence (not requiring a catheter), and reduction in back pain (not requiring a narcotic) one month after treatment.. Dexamethasone: 8 mg twice daily was given to both arms and tapered after completion of radiotherapy.<br/> <sup>2</sup> Serious indirectness: the trial included those usually given short courses of radiotherapy (patients with poor prognosis; no spinal instability or bony impingement causing cord compression). However this trial is from a high‐income country where early diagnosis and early institution of radiotherapy (within 24 hours after diagnosis) was possible; these may not be possible in many low‐ and middle‐income settings. Downgraded 1 level.<br/> <sup>3</sup> No imprecision: the trial was powered to demonstrate equivalence in response rates post‐treatment and the difference in response rates with the two radiotherapy schedules was within the pre‐set precision limits. Not downgraded.<br/> <sup>4</sup> Serious imprecision: the trial was not powered to detect equivalence for this outcome.. The number of events were few, and the 95% CI of the risk difference indicated non‐appreciable benefits with both schedules. The sample size was smaller than the optimal sample size. Downgraded 1 level. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006716-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Laminectomy plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Laminectomy plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with metastatic extradural spinal cord compression (single lesion, no prior radiotherapy, fit for surgery)<br/> <b>Intervention:</b> laminectomy plus radiotherapy<br/> <b>Comparison:</b> radiotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Radiotherapy </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Laminectomy plus radiotherapy </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ambulation</b> </p> <p>At four months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>385 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>373 per 1000</b><br/> (146 to 954) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.98</b> <br/> (0.38 to 2.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study<sup>1</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4</sup> </p> <p>(risk of bias, serious indirectness, very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laminectomy followed by radiotherapy may offer no advantage over radiotherapy alone in enhancing ambulation. . </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival</b> </p> <p>At four months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>462 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>563 per 1000</b><br/> (272 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.22</b> <br/> (0.59 to 2.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> <p>(serious indirectness, very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laminectomy followed by radiotherapy may offer no advantage over radiotherapy alone in improving survival. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in analgesic use</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>440 per 1000</b><br/> (210 to 905) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.88</b> <br/> (0.42 to 1.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> <p>(serious indirectness, very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laminectomy followed by radiotherapy may offer no advantage over radiotherapy alone in reducing analgesic use. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary continence</b> </p> <p>One month after treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>538 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>32 more per 1000</b><br/> (232 fewer to 538 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.06</b> <br/> (0.57 to 2.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4</sup> </p> <p>(risk of bias, serious indirectness, very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laminectomy followed by radiotherapy may offer no advantage over radiotherapy alone in enhancing urinary continence. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Local recurrence</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adverse events were reported with laminectomy plus RT or with RT, but it is unclear if these were systematically ascertained </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Data from <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>: radiotherapy was given as 30 Gy in 10 fractions (4 Gy/day first 3 days, then 18 Gy in 7 fractions over 14 days), Both arms were given dexamethasone 12 mg; followed by 4 mg four times daily till radiotherapy completion. </p> <p><sup>2</sup> Serious risk of bias. There were baseline imbalances in the proportions with myelographic block and this negatively influenced effect estimates for the outcomes of ambulation and urinary continence. Downgraded 1 level.<br/> <sup>3</sup> Serious indirectness: the trial included those likely to be offered a surgical intervention in preference to radiotherapy. However, the data for the comparative effects of laminectomy versus radiotherapy come from only one small trial done over 30 years ago. Downgraded 1 level.<br/> <sup>4</sup> Very serious imprecision. The 95% CI of the effect estimate indicates appreciable benefits for both interventions. The number of events and participants were too few to provide reliable estimates. Downgraded by 2 levels. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006716-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Decompressive surgery plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Decompressive surgery plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with metastatic extradural spinal cord compression (fit for surgery, paraplegic less than 48 hours, and without multiple discrete compressions or radiosensitive tumours; with cervical or thoracic lesions, and life expectancy three months or more)<br/> <b>Intervention:</b> decompressive surgery plus radiotherapy<br/> <b>Comparison:</b> radiotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Radiotherapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Decompressive surgery plus radiotherapy </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ambulation</b> </p> <p>Immediately after completing RT</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>569 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>842 per 1000</b><br/> (660 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.48</b> <br/> (1.16 to 1.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101<br/> (1 study<sup>1</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> <p>(serious indirectness, serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery plus RT may be superior to RT in enhancing ambulation (maintaining ambulation: and regaining ambulation) in selected patients with MESCC </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival (short term)</b> </p> <p>At 30 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>863 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>940 per 1000</b><br/> (828 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.09</b> <br/> (0.96 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> <p>(serious indirectness, serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery plus RT may not significantly enhance proportions surviving compared to RT (though median survival may be longer with surgery plus RT: 126 days versus 100 days). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in analgesic and narcotic use</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery plus RT may have beneficial effects compared to RT in reducing analgesic use (median daily morphine equivalent dose: 0·4 mg (0 to 60 mg) versus 4·8 mg (0 to 200 mg; P = 0·002). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary continence</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery plus RT may have beneficial effects compared to RT in enhancing the maintenance of urinary continence (median duration for maintenance of continence: 156 days versus 17 days; P = 0.016)<sup>4</sup>. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Local recurrence</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were seen after surgery or after RT. In 10 participants randomised to RT who subsequently had surgery, 4 (40%) had surgical complications (wound infections‐3; failure of fixation‐1). Other adverse events were not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Data from <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>: surgery ‐ direct circumferential decompression with or without stabilisation within 24 hours of randomisation; Radiotherapy‐ 3 Gy x 10, starting within 24 hours after randomisation (in most), or within 14 days of surgery. All patients were given 100 mg dexamethasone immediately at diagnosis, then 24 mg every 6 hours until the start of radiotherapy or surgery, after which steroids were then reduced and continued until completion of radiotherapy.<br/> <sup>2</sup> Serious indirectness: this trial selected patients who were good candidates for surgery and excluded participants with radiosensitive tumours; 18 patients given RT had unstable spines. These biased the results against radiotherapy and the participants given RT were not representative of the usual candidates for RT. Emergency surgery was offered within 24 hours of the diagnosis of cord compression, within 48 hours of onset of paraplegia and within two weeks of the onset of symptoms in most. RT was also offered as an emergency. These may not be feasible outside a clinical trial setting and in healthcare systems in resource poor countries. Downgraded 1 level.<br/> <sup>3</sup> Serious imprecision. This trial was stopped early for apparent benefit after recruiting only 50% of the estimates sample. Truncated RCTs are at risk of over‐estimating benefits (<a href="./references#CD006716-bbs2-0020" title="BasslerD , BrielM , MontoriVM , LaneM , GlasziouP , ZhouQ , et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta‐regression analysis. JAMA2010;303(12):1180‐7. ">Bassler 2010</a>). The evidence in favour of surgery comes from only one trial with 101 participants, and the sample size is smaller than the optimal information size. Downgraded 1 level. </p> <p><sup>4</sup> Based on secondary analysis in the <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> report using a Cox model with all covariates included </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006716-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">High‐dose corticosteroids compared to moderate‐dose or no corticosteroids for adults with metastatic extradural spinal cord compression</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>High‐dose corticosteroids compared to moderate‐dose or no corticosteroids for adults with metastatic extradural spinal cord compression</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with metastatic extradural spinal cord compression (without peptic ulceration or infection; mixed prognosis)<br/> <b>Intervention:</b> high‐dose corticosteroids (96 mg and 100 mg bolus)<br/> <b>Comparison:</b> moderate‐dose (10 mg and 16 mg) or no corticosteroids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Moderate‐dose or no corticosteroids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>High dose corticosteroids</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ambulation</b> </p> <p>Follow‐up: one week to three months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>550 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>594 per 1000</b><br/> (446 to 798) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.08</b> <br/> (0.81 to 1.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105<br/> (3 studies<sup>1</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> <p>(very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High dose steroids may not offer any beneficial effects compared to moderate dose steroids in enhancing ambulation. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival (long term)</b> </p> <p>Over two years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>111 per 1000</b><br/> (25 to 505) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.11</b> <br/> (0.24 to 5.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> <p>(very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High dose steroids may offer no beneficial effects compared to no steroids in enhancing long term survival. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain reduction</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>909 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>782 per 1000</b><br/> (564 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.86</b> <br/> (0.62 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> <p>(very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High dose steroids may offer no beneficial effects compared to moderate dose steroids in reducing pain. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary continence</b> </p> <p>One week after treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>533 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>629 per 1000</b><br/> (352 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.18</b> <br/> (0.66 to 2.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> <p>(very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High dose steroids may offer no beneficial effects compared to moderate dose steroids in enhancing urinary continence. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Local recurrence</b> ‐ </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 8.02</b> <br/> (1.03 to 62.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> <p>(serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events (such as perforated gastric ulcer, psychoses and deaths due to infection) occurred only with high dose steroids: 6/36 (17%) versus 0/41 (0%) on moderate dose (N = 11) or no steroids (N = 30). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across studies for pooled data or the control group risk in single studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup><a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a> and <a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a> compared high dose (100 to 96 mg dexamethazone) versus moderate dose steroids (10 to 16 mg); <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a> compared a single IV dose of 100 mg dexamethazone with saline placebo. The three trials were free of the risk of serious biases for efficacy outcomes.<br/> <sup>2</sup> Very serious imprecision: the 95% CI of the effect estimates indicate appreciable benefit for high dose and moderate dose or no steroids. Downgraded 2 levels. </p> <p><sup>3</sup> Serious imprecision: the 95% CI of the effect estimate indicates appreciable and non‐appreciable benefits with moderate dose or no steroids; and the number of events and participants were too few to provide reliable estimates. Downgraded 1 level. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006716-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006716-sec-0023"></div> <p>This review is an update of a previously published review titled, 'Interventions for the treatment of metastatic extradural spinal cord compression in adults' that was published in the<i>Cochrane Database of Systematic Reviews</i> (Issue 4, 2008) in <i>The Cochrane Library</i> (<a href="./references#CD006716-bbs2-0075" title="GeorgeR , JebaJ , RamkumarG , ChackoAG , LengM , TharyanP . Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD006716] ">George 2008</a>). </p> <section id="CD006716-sec-0024"> <h3 class="title" id="CD006716-sec-0024">Description of the condition</h3> <p>Cancer that spreads to the spinal column, if untreated, can result in back pain, paraplegia, tetraplegia, urinary and bowel incontinence (<a href="./references#CD006716-bbs2-0041" title="LoblawDA , LaperriereNJ . Emergency treatment of malignant spinal cord compression: an evidence based guideline. Journal of Clinical Oncology1998;16(4):1613‐24. ">Loblaw 1998</a>; <a href="./references#CD006716-bbs2-0036" title="HoltT , HoskinP , MaranzanoE , SahgalA , SchildSE , RyuS , et al. Malignant epidural spinal cord compression: the role of external beam radiotherapy. Current Opinion in Supportive and Palliative Care2012;6(1):103‐8. ">Holt 2012</a>). Metastatic extradural spinal cord compression (MESCC) is defined as "the compression of the dural sac and its contents, spinal cord or cauda equina, or both, by an extradural tumour mass. The minimum radiologic evidence for cord compression is indentation of the theca, at the level of clinical features" (<a href="./references#CD006716-bbs2-0040" title="LaperriereNJ . The management of spinal cord compression. Toronto, Ontario, Canada, Princess Margaret Hospital1996. ">Laperriere 1996</a>; <a href="./references#CD006716-bbs2-0041" title="LoblawDA , LaperriereNJ . Emergency treatment of malignant spinal cord compression: an evidence based guideline. Journal of Clinical Oncology1998;16(4):1613‐24. ">Loblaw 1998</a>). In this definition, and in clinical practice, the term metastatic spinal cord compression refers to compression of the cord itself, or of the cauda equina more distally within the spinal canal. </p> <p>Up to 40% of all people with cancer develop spinal metastases (<a href="./references#CD006716-bbs2-0074" title="WongDA , FornasierVL , MacNabI . Spinal metastases: the obvious, the occult, and the impostors. Spine1990;15:1‐4. ">Wong 1990</a>); and in 10% to 20% this can progress to symptomatic cord compression (<a href="./references#CD006716-bbs2-0062" title="SchabergJ , GainorBJ . A profile of metastatic carcinoma of the spine. Spine1985;10:19‐20. ">Schaberg 1985</a>; <a href="./references#CD006716-bbs2-0038" title="KlimoP , SchmidtMH . Surgical management of spinal metastases. Oncologist2004;9(2):188‐96. ">Klimo 2004</a>). A population‐based study in Canada estimated that at least 2.5% of all people with cancer experienced one or more episodes of spinal cord compression in the five years preceding death (<a href="./references#CD006716-bbs2-0042" title="LoblawDA , LaperriereNJ , MackillopWJ . A population‐based study of malignant spinal cord compression in Ontario. Clinical Oncology (R Coll Radiol)2003;15(4):211‐7. ">Loblaw 2003</a>). In this study, the cumulative five‐year incidence of cord compression in different types of cancer were: myeloma 8%; prostate 7%; nasopharynx 6.5%; lung 6%; breast 5.5%; kidney 5%; cervix 2.5%; head and neck 0.9%; colorectum 0.8% and stomach 0.6% (<a href="./references#CD006716-bbs2-0042" title="LoblawDA , LaperriereNJ , MackillopWJ . A population‐based study of malignant spinal cord compression in Ontario. Clinical Oncology (R Coll Radiol)2003;15(4):211‐7. ">Loblaw 2003</a>). The vast majority of spinal metastases in people with MESCC are found in the vertebral body with or without extension into the posterior elements; and also into paravertebral regions and the epidural space; these metastases most commonly affect the thoracic spine (70%), followed by the lumbar spine (20%), and less commonly the cervical spine, and sacrum (<a href="./references#CD006716-bbs2-0064" title="SciubbaDM , PetteysRJ , DekutoskiMB , FisherCG , FehlingsMG , OndraSL , et al. Diagnosis and management of metastatic spine disease. A review. Journal of Neurosurgery. Spine2010;13(1):94‐108. ">Sciubba 2010</a>). MESCC occurs when tumour elements or bone fragments displace the spinal cord within the canal. </p> <p>MESCC is a condition that can cause significant morbidity and disability in large numbers of people across a spectrum of cancers. However there is surprisingly little evidence to guide clinicians and patients in choosing appropriate treatments. </p> </section> <section id="CD006716-sec-0025"> <h3 class="title" id="CD006716-sec-0025">Description of the intervention</h3> <p>Early detection, with magnetic resonance imaging (MRI) as the preferred imaging modality; and measures to avoid delays in treatment are recommended in the management of people with MESCC (<a href="./references#CD006716-bbs2-0043" title="LoblawA , PerryJ , ChambersA , LaperriereNJ . Systematic review of the diagnosis and management of malignant extradural spinal cord compression: The Cancer Care Ontario Practice Guidelines Initiative's Neuro‐oncology Disease Site Group. Journal of Clinical Oncology2005;23:2028‐37. ">Loblaw 2005</a>). Corticosteroids, radiotherapy and surgery are the treatments currently used for MESCC. The management of cancer pain usually involves the use of non‐steroidal anti‐inflammatory drugs (NSAIDs) therapy with mild and strong opioids, titrated to the severity of pain. </p> </section> <section id="CD006716-sec-0026"> <h3 class="title" id="CD006716-sec-0026">How the intervention might work</h3> <section id="CD006716-sec-0027"> <h4 class="title">Corticosteroids</h4> <p>Corticosteroids reduce inflammation, oedema and pain; and are recommended both for immediate treatment and as an adjunct to radiotherapy or surgery, especially in patients with neurologic deficits (<a href="./references#CD006716-bbs2-0050" title="National Institute for Clinical Excellence (NICE). CG 75 Metastatic spinal cord compression. Available at: http://guidance.nice.org.uk/CG75/NICEGuidance/pdf 2008 (accessed 10 December 2013). ">NICE 2008</a>; <a href="./references#CD006716-bbs2-0044" title="LoblawDA , MiteraG , FordM , LaperriereNJ . A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2012;84(2):312‐7. ">Loblaw 2012</a>). Corticosteroids have demonstrated neurological improvement in human studies (<a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a>); and in rat experimental models of epidural tumours (<a href="./references#CD006716-bbs2-0069" title="UshioY , PosnerR , PosnerJB , ShapiroWR . Experimental spinal cord compression by epidural neoplasms. Neurology1977; Vol. 27, issue 5:422‐9. ">Ushio 1977</a>). The British and Canadian guidelines recommend starting with doses of around 16 mg per day (<a href="./references#CD006716-bbs2-0050" title="National Institute for Clinical Excellence (NICE). CG 75 Metastatic spinal cord compression. Available at: http://guidance.nice.org.uk/CG75/NICEGuidance/pdf 2008 (accessed 10 December 2013). ">NICE 2008</a>; <a href="./references#CD006716-bbs2-0045" title="L'espéranceS , VincentF , GaudreaultM , OuelletJA , LiM , TosikyanA , GouletS , Comité de l’évolution des pratiques enoncologie . Treatment of metastatic spinal cord compression: cepo review and clinical recommendations.. Current Oncology2012;19(6):e478‐90. ">L’espérance 2012</a>; <a href="./references#CD006716-bbs2-0044" title="LoblawDA , MiteraG , FordM , LaperriereNJ . A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2012;84(2):312‐7. ">Loblaw 2012</a>) although some authors use doses up to 100 mg (<a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>). In clinical practice corticosteroid doses vary widely. Studies have found a significant increase in serious adverse effects with high‐dose corticosteroids. In a case control study, 14% of patients receiving 96 mg per day of dexamethasone developed serious adverse events, as compared to 0% of those receiving 16 mg per day (<a href="./references#CD006716-bbs2-0025" title="DelattreJY , ArbitE , ThalerHT , RosenblumMK , PosnerJB . A dose‐response study of dexamethasone in a model of spinal cord compression caused by epidural tumor. Journal of Neurosurgery1989;70(6):920‐5. ">Delattre 1989</a>; <a href="./references#CD006716-bbs2-0031" title="HeimdalK , HirschbergH , SletteboH , WatneK , NomeO . High incidence of serious side effects of high‐dose dexamethasone treatment in patients with epidural spinal cord compression. Journal of Neuroncology1992;12(2):141‐4. ">Heimdal 1992</a>). </p> </section> <section id="CD006716-sec-0028"> <h4 class="title">Radiotherapy</h4> <p>Radiotherapy is the most commonly used definitive treatment modality. Radiation therapy can cause the tumour to shrink thereby reducing pressure; pain relief may also occur due to reduced pressure as well through neuropathic components. The outcome of radiotherapy depends on the pre‐ treatment neurologic status. Awareness, early detection and rapid access to treatment are crucial (<a href="./references#CD006716-bbs2-0043" title="LoblawA , PerryJ , ChambersA , LaperriereNJ . Systematic review of the diagnosis and management of malignant extradural spinal cord compression: The Cancer Care Ontario Practice Guidelines Initiative's Neuro‐oncology Disease Site Group. Journal of Clinical Oncology2005;23:2028‐37. ">Loblaw 2005</a>, <a href="./references#CD006716-bbs2-0046" title="MaranzanoE , LatiniP , CheccagliniF , RicciS , PanizzaBM , AristeiC , et al. Radiation therapy in metastatic spinal cord compression. A prospective analysis of 105 consecutive patients. Cancer1991;67(5):1311‐7. ">Maranzano 1991</a>; <a href="./references#CD006716-bbs2-0050" title="National Institute for Clinical Excellence (NICE). CG 75 Metastatic spinal cord compression. Available at: http://guidance.nice.org.uk/CG75/NICEGuidance/pdf 2008 (accessed 10 December 2013). ">NICE 2008</a>). A review of prospective non‐randomised studies found that 94% of those who could walk unassisted before radiotherapy and 63% of those who needed assistance for walking, retained ambulation after radiotherapy. Much poorer outcomes were seen in patients who were already paraplegic (12%) or paraparetic (38%) (<a href="./references#CD006716-bbs2-0043" title="LoblawA , PerryJ , ChambersA , LaperriereNJ . Systematic review of the diagnosis and management of malignant extradural spinal cord compression: The Cancer Care Ontario Practice Guidelines Initiative's Neuro‐oncology Disease Site Group. Journal of Clinical Oncology2005;23:2028‐37. ">Loblaw 2005</a>). </p> <p>The total dose and the number of radiotherapy treatment fractions vary widely (<a href="./references#CD006716-bbs2-0026" title="FalkmerU , JarhultJ , WersallP , Cavallin‐StahlE . A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncologica2003;42(5/6):620‐33. ">Falkmer 2003</a>; <a href="./references#CD006716-bbs2-0043" title="LoblawA , PerryJ , ChambersA , LaperriereNJ . Systematic review of the diagnosis and management of malignant extradural spinal cord compression: The Cancer Care Ontario Practice Guidelines Initiative's Neuro‐oncology Disease Site Group. Journal of Clinical Oncology2005;23:2028‐37. ">Loblaw 2005</a>; <a href="./references#CD006716-bbs2-0044" title="LoblawDA , MiteraG , FordM , LaperriereNJ . A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2012;84(2):312‐7. ">Loblaw 2012</a>; <a href="./references#CD006716-bbs2-0052" title="RadesD , FehlauerF , StalpersLJ , WildfangI , ZschenkerO , SchildSE . A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study. Cancer2004;101(11):2687‐92. ">Rades 2004</a>; <a href="./references#CD006716-bbs2-0053" title="RadesD , FehlauerF , SchulteR , VeningaT , StalpersLJ , BasicH , et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. Journal of Clinical Oncology2006;20(24):3388‐93. ">Rades 2006</a>; <a href="./references#CD006716-bbs2-0054" title="RadesD , RudatV , VeningaT , StalpersLJ , HoskinPJ , SchildSE . Prognostic factors for functional outcome and survival after re‐irradiation for in‐ﬁeld recurrences of metastatic spinal cord compression. Cancer2008;113:1090‐6. ">Rades 2008</a>; <a href="./references#CD006716-bbs2-0057" title="RadesD , LangeM , VeningaT , StalpersLJ , BajrovicA , AdamietzIA , et al. Final results of a prospective study comparing the local control of short‐course and long‐course radiotherapy for metastatic spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2011;79(2):524‐30. ">Rades 2011a</a>). In a prospective non‐randomised study that recruited patients with motor deficits in Holland and Germany (‘SCORE‐1’), patients in Holland received short‐course radiotherapy (1 × 8 Gray (Gy) or 5 × 4 Gy) completing treatment within a day or one week. Patients in Germany were treated for two to four weeks with long‐course RT (10 × 3 Gy, 15 × 2.5 Gy or 20 × 2 Gy). Improvement in motor function (37% versus 39%) and one–year overall survival rates (23% versus 30%) were similar, but local control, (61% versus 81%) was significantly better in those who received long‐course radiotherapy (<a href="./references#CD006716-bbs2-0057" title="RadesD , LangeM , VeningaT , StalpersLJ , BajrovicA , AdamietzIA , et al. Final results of a prospective study comparing the local control of short‐course and long‐course radiotherapy for metastatic spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2011;79(2):524‐30. ">Rades 2011a</a>). The median survival was less than six months. The investigators concluded that short courses would suffice in patients with a poor prognosis. Longer courses and close follow‐up would be needed in those who were likely to live long enough to develop a local recurrence. </p> </section> <section id="CD006716-sec-0029"> <h4 class="title">Surgery</h4> <p>The main goals of surgery in metastatic spine disease are relief of pain, spine stabilisation and preservation or improvement in neurological function. In addition, many clinicians would consider surgery only if the expected survival was greater than three months (<a href="./references#CD006716-bbs2-0064" title="SciubbaDM , PetteysRJ , DekutoskiMB , FisherCG , FehlingsMG , OndraSL , et al. Diagnosis and management of metastatic spine disease. A review. Journal of Neurosurgery. Spine2010;13(1):94‐108. ">Sciubba 2010</a>). Early surgical treatments such as laminectomy were abandoned as laminectomy alone does not address metastatic disease that is primarily in the vertebral body and the ensuing instability after laminectomy does not make the procedure worthwhile. Ventral approaches on the other hand directly deal with the tumour and provide adequate opportunity for interbody fusion. </p> <p>A review of studies published from 1964 to 2005 clearly showed that outcomes improved with passing years with the introduction of more aggressive surgical approaches; and the addition of posterior stabilisation after laminectomy followed by RT resulted in substantial improvement in motor function and pain relief with similar mortality rates as laminectomy alone; whereas there was no difference in outcomes in studies using RT alone and in those comparing laminectomy with RT (<a href="./references#CD006716-bbs2-0073" title="WithamTF , KhavkinYA , GalliaGL , WolinskyJP , GokaslanZL . Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nature Clinical Practice Neurology2006;2:87‐94. ">Witham 2006</a>). However, using anterior decompression with stabilisation demonstrated better motor outcomes but with higher mortality. <a href="./references#CD006716-bbs2-0039" title="KlimoP , ThompsonCJ , KestleJRW , SchmidtMHS . A meta‐analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro‐oncology2005;7(1):64‐76. ">Klimo 2005</a>, in a meta‐analysis of non‐randomised single‐arm radiotherapy and surgical case series, demonstrated that overall ambulatory success rates for surgery and radiation were 85% and 64% respectively. People who had recently lost the ability to walk were more than twice as likely to regain mobility with surgery compared to radiotherapy. </p> <p>In people with MESCC with an unknown primary, either a percutaneous CT‐guided biopsy or open surgery and RT are recommended. In patients with radioresistant tumours causing extradural cord compression and instability, surgical decompression with fixation is recommended (<a href="./references#CD006716-bbs2-0064" title="SciubbaDM , PetteysRJ , DekutoskiMB , FisherCG , FehlingsMG , OndraSL , et al. Diagnosis and management of metastatic spine disease. A review. Journal of Neurosurgery. Spine2010;13(1):94‐108. ">Sciubba 2010</a>). </p> <p>Minimally invasive surgical procedures such as Video‐Assisted Thoracostomy (VAST), Endoscopy‐Assisted Posterior Decompression, and Minimal Access Spine Surgery (MASS), have been reported to offer benefit in people in whom aggressive surgeries are not feasible due to comorbid conditions such as malnourishment and diminished immune systems that make extensive surgical procedures unfeasible. Decreased complication rates, blood loss, and length of stay are considered to be among the benefits of minimally invasive surgery compared to open surgery, but their effects have to date been evaluated only by case reports, case series or retrospective study designs and these designs cannot accurately quantify their efficacy of effectiveness (<a href="./references#CD006716-bbs2-0049" title="MolinaCA , GokaslanZL , SciubbaDM . A systematic review of the current role of minimally invasive spine surgery in the management of metastatic spine disease. International Journal of Surgical Oncology2011;2011:598148. [DOI: 10.1155/2011/598148] ">Molina 2011</a>). Their relative efficacy and safety compared to external radiotherapy is also unclear. </p> </section> <section id="CD006716-sec-0030"> <h4 class="title">The relationship between treatment modality and prognosis</h4> <p>It is important to identify patients who would benefit from major spine surgery, minimally invasive surgery, or long courses of radiotherapy to optimise ambulation, pain relief and survival. In the earlier version of this review, we had discussed the need for good prognostic scoring systems, preferably based on hazard ratios from prospective studies or randomised trials (<a href="./references#CD006716-bbs2-0075" title="GeorgeR , JebaJ , RamkumarG , ChackoAG , LengM , TharyanP . Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD006716] ">George 2008</a>). </p> <p>Important prognostic factors for survival can be classified into the following domains:</p> <p>1. The cancer: primary site, visceral metastases, skeletal metastases;</p> <p>2.The patient’s condition: Karnofsky performance status, ability to walk;</p> <p>3. The time course: the rate of tumour growth or rapidity of motor deficits, interval from the diagnosis of cancer (<a href="./references#CD006716-bbs2-0046" title="MaranzanoE , LatiniP , CheccagliniF , RicciS , PanizzaBM , AristeiC , et al. Radiation therapy in metastatic spinal cord compression. A prospective analysis of 105 consecutive patients. Cancer1991;67(5):1311‐7. ">Maranzano 1991</a>; <a href="./references#CD006716-bbs2-0032" title="Helweg‐LarsenS , SorensenPS , KreinerS . Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables including survival and gait function in 153 patients. International Journal of Radiation Oncology, Biology and Physics2000;46(5):1163‐9. ">Helweg‐Larsen 2000</a>; <a href="./references#CD006716-bbs2-0051" title="RadesD , BlachM , BremerM , WildfangI , KarstensJH , HeidenreichF . Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: one‐year results of a prospective trial. International Journal of Radiation Oncology Biology Physics2000;48(5):1403‐8. ">Rades 2000</a>; <a href="./references#CD006716-bbs2-0052" title="RadesD , FehlauerF , StalpersLJ , WildfangI , ZschenkerO , SchildSE . A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study. Cancer2004;101(11):2687‐92. ">Rades 2004</a>; <a href="./references#CD006716-bbs2-0071" title="WangJC , BolandP , MitraN , YamadaY , LisE , StubblefieldM , et al. Single‐stage posterolateral transpedicular approach for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: results in 140 patients. Journal of Neurosurgery. Spine2004;1(3):287‐98. ">Wang 2004</a>; <a href="./references#CD006716-bbs2-0070" title="Van derLindenYM , DijkstraSP , VonkEJ , MarijnenCA , LeerJW , Dutch Bone Metastasis Study Group. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer2005;103(2):320‐8. ">Van der Linden 2005</a>). </p> <p>A number of prognostic scoring systems are available:</p> <p>The Global Spine Tumour Study Group, an international group of spine surgeons, recommends the use of the Tomita and the Tokuhashi scoring systems (<a href="./references#CD006716-bbs2-0066" title="TokuhashiY , MatsuzakiH , OdaH , OshimaM , RyuJ . A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976)2005;30(9):2186‐91. ">Tokuhashi 2005</a>; <a href="./references#CD006716-bbs2-0067" title="TokuhashiY , AjiroY , UmezawaN . Outcome of treatment for spinal metastases using scoring system for preoperative evaluation of prognosis. Spine (Phila Pa 1976)2009;34(1):69‐73. ">Tokuhashi 2009</a>; <a href="./references#CD006716-bbs2-0068" title="TomitaK , KawaharaN , KobayashiT , YoshidaA , MurakamiH , AkamaruT . Surgical strategy for spinal metastases. Spine2001;26(3):298‐306. ">Tomita 2001</a>). The group have also initiated prospective data recording to refine a better score for surgical decision making (<a href="./references#CD006716-bbs2-0022" title="ChoiD , CrockardA , BungerC , HarmsJ , KawaharaN , MazelC , et al. Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. European Spine Journal2010;19(2):215‐22. ">Choi 2010</a>). For patients in whom radiotherapy is planned, prognostic scores can help to choose between long‐course radiotherapy, short‐course radiotherapy and supportive care (<a href="./references#CD006716-bbs2-0055" title="RadesD , DouglasS , VeningaT , StalpersLJ , HoskinPJ , BajrovicA , et al. Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer2010;116(15):3670‐3. ">Rades 2010a</a>; <a href="./references#CD006716-bbs2-0060" title="RadesD , VeningaT , BajrovicA , KarstensJH , SchildSE . A validated scoring system to identify long‐term survivors after radiotherapy for metastatic spinal cord compression. Strahlentherapie und Onkologie2013;189(6):462‐6. ">Rades 2013</a>). </p> </section> </section> <section id="CD006716-sec-0031"> <h3 class="title" id="CD006716-sec-0031">Why it is important to do this review</h3> <p>The original review identified six trials that randomised 544 adults with MESCC to different treatment regimens: short‐course radiotherapy (16 Gy in two doses over a week) versus split‐course radiotherapy (30 Gy in eight doses over two weeks); laminectomy followed by radiotherapy versus radiotherapy; decompressive surgery followed by radiotherapy versus conventional radiotherapy; and different doses of corticosteroids or no steroids in people undergoing radiotherapy for MESCC (<a href="./references#CD006716-bbs2-0075" title="GeorgeR , JebaJ , RamkumarG , ChackoAG , LengM , TharyanP . Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD006716] ">George 2008</a>). The results showed equal benefit with short‐course RT and the longer split courses of radiotherapy. There also was suggestive evidence for greater benefit with decompressive surgery and post‐operative radiation over radiotherapy alone, though uncertainties remained about the specific patient subgroups that decompression surgery was best indicated in. The evidence also suggested that serious adverse events were less frequent with moderate‐dose over high‐dose steroids in people undergoing radiation for MESCC. </p> <p>In this Cochrane review update we searched for additional trials evaluating the relative benefits and harms of surgery, radiotherapy, and corticosteroids. We incorporated the standard methods recommended for Cochrane Systematic Reviews (<a href="./references#CD006716-bbs2-0048" title="ChandlerJ , ChurchillR , HigginsJ , LassersonT , ToveyD . Methodological Expectations of Cochrane Intervention Reviews (MECIR). Methodological standards for the conduct of new Cochrane Intervention Reviews. Version 2.1, 8 December 2011. Available at: http://www.editorial‐unit.cochrane.org/sites/editorial‐unit.cochrane.org/files/uploads/MECIR_conduct_standards%202.1.pdf (accessed on 27 March 2012). ">MECIR 2011</a>) that includes more detailed 'risk of bias' assessments than were undertaken in the previous version of this review. We also summarised findings for comparisons using the GRADE approach (<a href="./references#CD006716-bbs2-0063" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results drawing conclusions. Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. ">Schünemann 2011</a>) that links the effect estimates for important outcomes with the overall confidence one can place in these estimates. As in the previous review, we noted, where reported, the prognostic factors that predicted survival and ambulatory outcomes, in order to discriminate between people who clearly benefit from combined modalities of treatment, those who do well with single modalities of treatment alone, and those with poor prognosis who should be spared complex or prolonged courses of treatment. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006716-sec-0032" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006716-sec-0032"></div> <p>Our primary objective was to compare the efficacy and harm of treating extradural spinal cord compression for the following: </p> <p> <ol id="CD006716-list-0001"> <li> <p>different schedules of radiation therapy;</p> </li> <li> <p>surgery with or without radiation therapy versus radiation therapy alone;</p> </li> <li> <p>the administration of high‐dose corticosteroids (more than 32 mg of dexamethasone equivalent), versus moderate dose (less than 32 mg), or no corticosteroids; with or without surgery/radiotherapy. </p> </li> </ol> </p> <p>Our secondary objectives were:</p> <p> <ol id="CD006716-list-0002"> <li> <p>to compare the adverse effects of surgery, radiotherapy and corticosteroids for metastatic spinal cord compression; </p> </li> <li> <p>to ascertain if the clinical benefit, if any, was influenced by neurological and oncological factors such as ambulatory status, primary tumour type, duration of cord compression and the presence of visceral metastases, spinal instability or bony collapse. </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006716-sec-0033" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006716-sec-0033"></div> <section id="CD006716-sec-0034"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006716-sec-0035"> <h4 class="title">Types of studies</h4> <p>RCTs of surgery, radiotherapy or corticosteroids for spinal cord compression.</p> </section> <section id="CD006716-sec-0036"> <h4 class="title">Types of participants</h4> <p>People with clinical or radiological evidence of extradural spinal cord compression or cauda equina compression caused by metastatic cancer, or both. We sought trials involving adults (aged eighteen years or more), but would have included reports with younger people where the majority (&gt; 90%) of participants were adults. We included trials with participants who were ambulatory, or with paresis and paraplegia. We excluded trials of primary tumours of the spinal cord. </p> </section> <section id="CD006716-sec-0037"> <h4 class="title">Types of interventions</h4> <p> <ul id="CD006716-list-0003"> <li> <p>Conventional radiation treatment using any dose or fractionation schedule.</p> </li> <li> <p>Surgery (e.g. laminectomy, decompressive surgery, corpectomy, minimally invasive surgery) with or without radiotherapy versus radiotherapy alone. </p> </li> <li> <p>High‐dose corticosteroids versus moderate‐dose or no corticosteroids, with or without surgery/radiotherapy. </p> </li> </ul> </p> </section> <section id="CD006716-sec-0038"> <h4 class="title">Types of outcome measures</h4> <section id="CD006716-sec-0039"> <h5 class="title">Primary outcomes</h5> <section id="CD006716-sec-0040"> <h6 class="title">1. Ambulation</h6> <p> <ul id="CD006716-list-0004"> <li> <p>Overall ambulatory rates</p> </li> <li> <p>Proportion of patients maintaining ambulation</p> </li> <li> <p>Proportion of non‐ambulant patients regaining ambulation</p> </li> </ul> </p> </section> </section> <section id="CD006716-sec-0041"> <h5 class="title">Secondary outcomes</h5> <section id="CD006716-sec-0042"> <h6 class="title">2. Survival</h6> </section> <section id="CD006716-sec-0043"> <h6 class="title">3. Pain relief</h6> <p> <ul id="CD006716-list-0005"> <li> <p>Scores using validated pain scales</p> </li> </ul> <ul id="CD006716-list-0006"> <li> <p>Use of concomitant analgesics</p> </li> </ul> </p> </section> <section id="CD006716-sec-0044"> <h6 class="title">4. Urinary incontinence</h6> <p> <ul id="CD006716-list-0007"> <li> <p>Proportion of patients with bladder control</p> </li> <li> <p>Percentage of patients maintaining bladder control (absence of urinary catheter)</p> </li> <li> <p>Percentage of patients regaining bladder control (absence of urinary catheter)</p> </li> </ul> </p> </section> <section id="CD006716-sec-0045"> <h6 class="title">5. Local recurrence</h6> </section> <section id="CD006716-sec-0046"> <h6 class="title">6. Adverse effects as reported for:</h6> <p> <ul id="CD006716-list-0008"> <li> <p>Radiotherapy</p> </li> <li> <p>Surgery</p> </li> <li> <p>Corticosteroids</p> </li> </ul> </p> </section> <section id="CD006716-sec-0047"> <h6 class="title">7. Quality of life (participant‐ or caregiver‐rated)</h6> </section> <section id="CD006716-sec-0048"> <h6 class="title">8. Participant and caregiver satisfaction</h6> </section> <section id="CD006716-sec-0049"> <h6 class="title">9. Characteristics of participants who benefit from treatment</h6> <p>All outcomes were subgrouped as short term (less than four months), medium term (four months to a year) and long term (more than one year). </p> </section> </section> </section> </section> <section id="CD006716-sec-0050"> <h3 class="title">Search methods for identification of studies</h3> <p>We attempted to identify all relevant trials, regardless of language or publication status (published, unpublished, or ongoing). </p> <section id="CD006716-sec-0051"> <h4 class="title">Electronic searches</h4> <section id="CD006716-sec-0052"> <h5 class="title">Databases</h5> <p>On 3 March 2015, we updated previous searches (run in July 2008 and 17 December 2013) of the following electronic databases: </p> <p> <ul id="CD006716-list-0009"> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) in <i>The Cochrane Library</i> (Issue 2 of 12, 2015); </p> </li> <li> <p>MEDLINE &amp; Medline In‐Process (OVID) (1947 to 2nd March 2015);</p> </li> <li> <p>EMBASE (OVID) (1974 to 2nd March 2015);</p> </li> <li> <p>CINAHL (|EBSCO) (1982 to March 2015);</p> </li> <li> <p>LILACS (BIREME) (1982 to March 2015);</p> </li> <li> <p>CancerLit (PubMED) (2007 to March 2015).</p> </li> </ul> </p> <p>The search strategies used to search these databases are detailed in <a href="./appendices#CD006716-sec-0164">Appendix 1</a>. The strategies used for the 2008 search are provided in <a href="./appendices#CD006716-sec-0165">Appendix 2</a>. </p> </section> <section id="CD006716-sec-0053"> <h5 class="title">Clinical trials registries</h5> <p>We also searched clinical trials registers (<a href="http://www.clinicaltrials.gov/" target="_blank">http://www.clinicaltrials.gov/</a>; <a href="http://www.trialscentral.org" target="_blank">www.trialscentral.org</a>; <a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a>; <a href="http://www.nrr.nhs.uk" target="_blank">www.nrr.nhs.uk</a>; <a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>) for ongoing trials. </p> </section> </section> <section id="CD006716-sec-0054"> <h4 class="title">Searching other resources</h4> <section id="CD006716-sec-0055"> <h5 class="title">Conference abstracts</h5> <p>The electronic search included the following conference abstracts</p> <p> <ol id="CD006716-list-0010"> <li> <p>The 19th Annual Meeting of the American College of Radiation Oncology. Cancer Clinical Trials Conference: Las Vegas, United States 2009 </p> </li> <li> <p>The European Association of Neurosurgical Societies, EANS Annual Meeting, Groningen, Netherlands, 2010. </p> </li> <li> <p>43rd Congress of the International Society of Paediatric Oncology, Pediatric Blood and Cancer Conference, SIOP; Auckland, New Zealand, 2011 </p> </li> <li> <p>Proceedings of the 26th Annual Meeting of the North American Spine Society, NASS; Chicago, Illinois, USA, 2011 </p> </li> <li> <p>European Spine Journal Conference: Annual Meeting of the British Association of Spine Surgeons, BASS: Britspine; Newcastle upon Tyne, UK, 2012 </p> </li> <li> <p>Royal College of Radiologists, 2013 Clinical Radiology Annual Scientific Meeting, London, UK, 2013 </p> </li> <li> <p>European Spine Journal Conference: Annual Meeting of the British Association of Spine Surgeons, BASS: Britspine; Norwich, UK, 2013 </p> </li> <li> <p>96th Annual Meeting of the American Radium Society, St. Thomas, US Virgin Islands, 2014 </p> </li> <li> <p>American Society of Clinical Oncology Annual Meeting, Chicago, Illinois, USA, 2014</p> </li> </ol> </p> </section> <section id="CD006716-sec-0056"> <h5 class="title">Contacts</h5> <p>We contacted the first author of included trials for unpublished trials.</p> </section> <section id="CD006716-sec-0057"> <h5 class="title">Reference lists</h5> <p>We also searched the references of included trials for other relevant trials.</p> </section> </section> </section> <section id="CD006716-sec-0058"> <h3 class="title" id="CD006716-sec-0058">Data collection and analysis</h3> <section id="CD006716-sec-0059"> <h4 class="title">Selection of studies</h4> <p>For this update, RG, JJ, and PT independently screened and selected studies. We resolved differences regarding trial selection by consensus. </p> </section> <section id="CD006716-sec-0060"> <h4 class="title">Data extraction and management</h4> <p>For this update, RG, JJ, and PT independently extracted data and this was checked by the other authors. We used a standardised form to extract the following information: </p> <section id="CD006716-sec-0061"> <h5 class="title">Participant characteristics</h5> <p>The number of participants in the trial; age; gender; their performance and ambulatory status; the investigative techniques and definitions used to diagnose cord compression; the types of primary tumours and the presence or absence of visceral metastases; the duration and rapidity of onset of cord compression; the spinal level and the presence of spinal instability or vertebral collapse. </p> </section> <section id="CD006716-sec-0062"> <h5 class="title">Intervention details</h5> <p>The year, country and setting in which the trial was conducted; surgical procedures used; radiotherapy doses and schedules; names, and doses of corticosteroids; the provision of rehabilitation services; the timing of these interventions in relation to the development of cord compression and the use of opioids or other analgesics. </p> </section> <section id="CD006716-sec-0063"> <h5 class="title">Outcome data</h5> <p>Short‐term, intermediate and long‐term ambulatory and survival rates; the definition of ambulation used in the study; urinary sphincter function; the proportion of participants with pain relief or reduced analgesic use; the adverse effects of interventions; quality of life as assessed by any validated scale; and participant satisfaction. </p> </section> </section> <section id="CD006716-sec-0064"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Three authors (RG, JJ, PT) independently assessed the risk of bias in the included trial reports. We assessed the standard six components: sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other biases. For each of these components we assigned a judgement regarding the risk of bias as 'high risk', 'low risk', or 'unclear risk' (<a href="./references#CD006716-bbs2-0034" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). We attempted to contact the trial authors for clarifications if any of the six components were unclear or not stated in the report. We recorded the results in the standard tables in Review Manager (<a href="./references#CD006716-bbs2-0061" title="The Nordic Cochrane Centre. Review Manager (RevMan). Version Version 5.3. Copenhagen: The Cochrane Collaboration, 2014. ">RevMan 5.3</a>), and summarised the assessments in figures, and graphs. </p> </section> <section id="CD006716-sec-0065"> <h4 class="title">Measures of treatment effect</h4> <p>For binary outcomes, we calculated risk ratios (RR) with their 95% confidence intervals (CIs). For continuous outcomes we planned to calculate pooled mean differences (MD) and CIs for outcomes using similar measures. If dissimilar measures were used for similar outcomes from trials (such as quality of life scales that measured similar domains) data from these would have been combined using pooled standardised mean difference (SMD) and their 95% CIs. </p> </section> <section id="CD006716-sec-0066"> <h4 class="title">Unit of analysis issues</h4> <p>We analysed data at the participant level. Had included studies randomised participants to multiple treatment arms, we would have excluded data from intervention arms that were not relevant to this review. If all treatment arms were considered relevant, we would have attempted to combine data in meta‐analysis, if possible, using the methods described in <a href="./references#CD006716-bbs2-0035" title="HigginsJPT , DeeksJJ , AltmanDG . Chapter 16: Special topics in statistics. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>. </p> </section> <section id="CD006716-sec-0067"> <h4 class="title">Dealing with missing data</h4> <p>We attempted to obtain missing data from study authors. We conducted an intention‐to‐treat analysis in trials with no loss to follow‐up and complete‐case analysis for trials with incomplete follow‐up. We did not make any assumptions for missing data for outcomes due to difficulties in making valid assumptions about those lost to follow‐up, apart from what was reported in the trials. However, we used this information in making judgements about the risk of attrition bias and in making judgements about the overall quality of the evidence in summarising findings. </p> <p>Had there been continuous data for our outcomes of interest we would have reported these as presented in the original studies without making any assumptions about those lost to follow‐up. Where possible we would have reported endpoint data, and if both endpoint and change data were available for the same outcomes, then we would have reported only the former. </p> </section> <section id="CD006716-sec-0068"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity between the trials by examining forest plots for inconsistency in the direction or magnitude of the effect estimates and non‐overlapping confidence intervals. We used the Chi² test for heterogeneity with a 10% level of significance to detect inconsistency in study results that excluded random error, and the I<sup>2</sup> statistic to denote the percentage of inconsistency in results due to intertrial variability that exceeded random error (<a href="./references#CD006716-bbs2-0033" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>). In general, we interpreted I<sup>2</sup> values of 50% or greater to denote significant heterogeneity (<a href="./references#CD006716-bbs2-0033" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>), though we acknowledged that this cut‐off is arbitrary. We therefore interpreted I<sup>2</sup> values between 0% to 40% as possibly unimportant, 30% to 60% as possibly significant, 50% to 90% as possibly substantial, and 75% to 100% as possibly considerable; depending on whether the inconsistency in results was due to differences in the direction of effects estimates between trials, rather than due to differences in the magnitude of effects favouring an intervention; as well as the strength of the evidence for heterogeneity from the P value for the Chi² test for heterogeneity (<a href="./references#CD006716-bbs2-0024" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). </p> </section> <section id="CD006716-sec-0069"> <h4 class="title">Assessment of reporting biases</h4> <p>Had there been at least 10 trials in a meta‐analysis we would have considered assessing the likelihood of publication bias by examining the funnel plot for asymmetry due to small study effects. </p> </section> <section id="CD006716-sec-0070"> <h4 class="title">Data synthesis</h4> <p>We synthesised comparable data from more than one trial using the Mantel‐Haenszel method to derive pooled, weighted risk ratios in fixed‐effect meta‐analyses. We used the random‐effects model for data synthesis when heterogeneity was identified as significant (see above) and could not be explained by subgroup analyses (see below). If I<sup>2</sup> values had revealed substantial intertrial variability in effect estimates in excess of chance that were thought not to be due to variations in clinical or methodological attributes, we would have suggested caution in interpreting the pooled estimates. </p> </section> <section id="CD006716-sec-0071"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If heterogeneity had been identified as significant, and if data had been available, we would have conducted subgroup analyses according to the following categories: </p> <p> <ol id="CD006716-list-0011"> <li> <p>ambulant versus non‐ambulant patients</p> </li> <li> <p>the presence or absence of unfavourable radiological features such as bony instability, or vertebral collapse </p> </li> <li> <p>primary tumour type</p> </li> <li> <p>presence or absence of visceral metastases</p> </li> <li> <p>screening versus no screening for cord compression</p> </li> </ol> </p> <p>The included trials reported results separately for ambulant versus non‐ambulant participants and the results of these subgroups are reported as the proportions maintaining and regaining ambulation. </p> </section> <section id="CD006716-sec-0072"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses to investigate the robustness of the results of meta‐analyses if included trials were at high risk of bias, for any assumptions made in data analyses, and if trials had more than 20% lost to follow‐up. . </p> <section id="CD006716-sec-0073"> <h5 class="title">Summarising and interpreting results</h5> <p>We used the GRADE approach to interpret findings (<a href="./references#CD006716-bbs2-0063" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results drawing conclusions. Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. ">Schünemann 2011</a>); and used GRADE Profiler (<a href="./references#CD006716-bbs2-0029" title="JanBrozek , AndrewOxman , HolgerSchünemann . GRADEpro. Version 3.2 for Windows. GRADE Working Group, 2008. ">Gradepro 2008</a>) to import data from Review Manager (<a href="./references#CD006716-bbs2-0061" title="The Nordic Cochrane Centre. Review Manager (RevMan). Version Version 5.3. Copenhagen: The Cochrane Collaboration, 2014. ">RevMan 5.3</a>) to create 'Summary of findings' tables for each comparison included in this review. These tables provide information concerning the overall quality of the evidence from the trials, the magnitude of effect of the interventions examined, and the sum of available data on the primary outcome and selected secondary outcomes.The GRADE approach integrates evaluations regarding study limitations; unexplained inconsistency in the results; indirectness (how representative of clinical practice the populations studied were; the deviations from accepted practice in the way interventions and comparisons were given; the choice of outcomes as representative of those considered important to clinical decision making; and the methods used in assessing these outcomes); imprecision in the estimates (in terms of statistical significance as well as clinical importance); and the likelihood that publication bias affected the estimates. </p> <p>We selected the following outcomes that we considered important or critically important to clinical decision making for inclusion in these tables: </p> <p> <ol id="CD006716-list-0012"> <li> <p>Ambulation</p> </li> <li> <p>Survival</p> </li> <li> <p>Pain relief</p> </li> <li> <p>Urinary continence</p> </li> <li> <p>Local recurrence</p> </li> <li> <p>Adverse events</p> </li> <li> <p>Quality of life</p> </li> </ol> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006716-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006716-sec-0074"></div> <section id="CD006716-sec-0075"> <h3 class="title">Description of studies</h3> <section id="CD006716-sec-0076"> <h4 class="title">Results of the search</h4> <p>The 2008 search yielded 1255 citations (CENTRAL 114, MEDLINE 845, EMBASE 226, CINAHL 24, LILACS 22, CANCERLIT 24) of which we selected seven reports for evaluation; six trials were included in the review; one citation was referenced under excluded studies; and two on‐going studies were identified (<a href="./references#CD006716-bbs2-0075" title="GeorgeR , JebaJ , RamkumarG , ChackoAG , LengM , TharyanP . Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD006716] ">George 2008</a>). </p> <p>The update searches to March 2015 yielded 807 additional citations (CENTRAL 32, MEDLINE 295, EMBASE342, CINAHL 18, LILACS 19, CANCELIT 101), which after de‐duplication left 686 unique citations. Of these, full copies of 17 potentially eligible reports were obtained; the remainder were not relevant to this review. Of the 17 reports, seven studies (described in eight reports) were excluded (see <a href="./references#CD006716-sec-0177" title="">Characteristics of excluded studies</a>). Of the remaining nine reports, three pertaining to two new trials were selected for inclusion in this review update; one trial described in two reports is included in quantitative synthesis in this review (<a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>); while the other trial reported only as a conference abstract awaits assessment (<a href="./references#CD006716-bbs2-0016" title="Hegazy , M , Wahba , H . Single‐ versus multi‐fraction radiation treatment for metastatic spinal cord compression: Functional outcome study Neurology. Conference. 64th American Academy of Neurology Annual Meeting New Orleans, LA United States. Conference Start. 20120421 Conference End: 20120428. Conference Publication: (var.pagings). 22 April 2012. ">Hegazy 2012</a>). <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> and <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>, two of the six trials included in the 2008 review, are referenced along with the primary studies in this update. </p> <p>The two ongoing studies identified in the 2008 review are still recruiting participants (<a href="./references#CD006716-bbs2-0017" title="A randomised feasibility study of single fraction radiotherapy compared to multi‐fraction radiotherapy in patients with metastatic spinal cord compression. http://controlled‐trials.com, UK Clinical Trials Gateway. [CRUK‐UCL‐BRD‐07‐010; EU‐20863; NCT00727584] ">ISRCTN97555949</a>; <a href="./references#CD006716-bbs2-0018" title="A randomised phase III trial of two fractionation schemes in the treatment of malignant spinal cord compression (Spinal Cord Compression. ICORG 05‐03, V6). http://clinicaltrials.gov/show/NCT00968643. [CDR0000644307; EU‐20952; ICORG‐05‐03] ">NCT00968643</a>). </p> <p>The process of study selection is described in <a href="#CD006716-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD006716-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA flow diagram depicting study selection" data-id="CD006716-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow diagram depicting study selection</p> </div> </div> </div> </section> <section id="CD006716-sec-0077"> <h4 class="title">Included studies</h4> <p>This review update includes seven trials (described in 23 reports) that are detailed in '<a href="./references#CD006716-sec-0176" title="">Characteristics of included studies</a>' tables. Relevant aspects of these trials are summarised below. </p> <section id="CD006716-sec-0078"> <h5 class="title">Study design</h5> <p>The seven trials were randomised parallel group trials with two intervention arms. Three were conducted before 1995 (<a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a>; <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>; <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>); and the most recent trial was completed in 2007 (<a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>). One trial recruited participants over a period of 10 years (1992 to 2002) and was stopped early after recruiting 50% of the planned sample due to perceived benefit with one intervention (<a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>). Another trial also had difficulty in recruiting sufficient participants over a three‐year period (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>). </p> <p>Three of the trials used stratified randomisation: <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> stratified participants by treating institution, tumour type, ambulatory status and relative stability of the spine; <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a> stratified randomisation by primary tumour (breast or other cancers) and gait function (ambulant, non‐ambulant); <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a> stratified for carcinoma versus reticular malignancy. </p> <p>Two of the trials were powered to detect equivalence between interventions and achieved the required sample size and response rates within pre‐set precision limits to demonstrate this (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>). Only one included trial was registered in a clinical trials registry, and even this trial was retrospectively registered (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>). The duration of follow‐up in the trials ranged from one week after treatment (<a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>); to nearly five years (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>); with many trials following participants till death. </p> </section> <section id="CD006716-sec-0079"> <h5 class="title">Location</h5> <p><a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a> was conducted in a single institution while the remainder were multi‐institutional trials in the same country. None of the trials were conducted in low‐ or middle‐income countries. Two trials were conducted in Italy (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>); and two in the USA (<a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>; <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>). The other trials were conducted in Australia (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>); Denmark (<a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a>); and the Netherlands (<a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>). </p> </section> <section id="CD006716-sec-0080"> <h5 class="title">Participants</h5> <p>The seven trials randomised a total of 876 participants, 723 of whom were evaluable. The sample sizes of these trials ranged from 20 (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>); to 300 in <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; and 327 in <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>. All trials recruited more males than females, except <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a> that recruited more females (with the majority having primary breast malignancies). The age of participants in the trials ranged from 19 to 87 years. </p> <p>The trials used different criteria to select participants with MESCC. All trials required the presence of a primary non‐central nervous system tumour and the demonstration of cord compression by either MRI or CT (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>; <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>; <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>), or by myelogram in the older studies (<a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a>; <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>; <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>). Two trials specifically selected participants with a poor prognosis (life expectancy of six months or less, as defined by unfavourable histologies; or favourable histologies with poor performance status; or motor or sphincter dysfunction) (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>). The two trials of surgical interventions selected participants with a better prognosis (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>; and particularly <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>). </p> <p>The duration and rapidity of cord compression was not reported in any trial except <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>, where the onset of total paraplegia of less than 48 hours was an inclusion criterion. All trials except two reported the spinal level of cord compression (<a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>; <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>); the thoracic spine was the most commonly reported site of the compression in more than 50% of participants in these trials. Spinal instability was an exclusion criterion in three trials (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>; <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a>); was a stratifying variable in one trial (<a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>); and was not reported in the other trials. </p> </section> <section id="CD006716-sec-0081"> <h5 class="title">Interventions and comparisons</h5> <p>The seven trials evaluated different radiotherapy schedules (two trials), different surgical approaches with radiotherapy compared to radiotherapy alone (two trials); and high doses of corticosteroids versus moderate doses of steroids or no steroids (three trials). </p> <section id="CD006716-sec-0082"> <h6 class="title">1. Different radiotherapy doses and schedules</h6> <section id="CD006716-sec-0083"> <p><b>1.1 Single‐fraction radiotherapy (8 Gy) versus a short course of radiotherapy (two fractions of 8 Gy)</b></p> <p><a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>, in a multi‐centre trial in Italy, randomised 327 adults with MESCC with no indications for primary surgery (diagnostic doubt, vertebral instability or bony impingement as the cause of cord compression, or previous radiotherapy of the same area) and an estimated survival of six months or less (due to unfavourable histologies; or, if the primary tumour histology was favourable, with motor or sphincter dysfunction, or poor performance status). Participants were randomised to a single dose of radiation (8 Gy) or to a short course of radiotherapy (8 Gy × 2; delivered as 8 Gy, 6 days' rest, and then 8 Gy to a total dose of 16 Gy in 1 week). Screening was actively done for early diagnosis of MESCC with MRI or CT in those with back pain or osteolysis, or a positive bone scan, even in the absence of neurological clinical signs of spinal cord compression. Radiotherapy (RT) was started within 24/48 hours of the radiologic diagnosis and was delivered by a 4 to 18 MV linear accelerator. Parenteral dexamethasone (8 mg twice daily) was administered from the first day of clinical‐radiologic diagnosis until 4 to 5 days after the end of RT in both arms. Parenteral 5‐hydroxytryptamine‐3 receptor antagonists were also given to those in whom radiation included the upper abdomen (30% in each arm). Participants were assessed one month after the end of RT and the follow‐up examination was continued once a month for one year, and four times per year until death. Of the 327 randomised, 303 (93%) were evaluable. The median follow‐up was 36 months (range 4 to 58 months). </p> <p>Of the 327 randomised, 134 (44%) had bone and visceral metastases (liver, lung, brain or a combination); 271 (89%) had back pain; 199 (65%) were able to walk pre‐treatment (114 (37%) without support and 85 (28%) with support); 78 (26%) were non‐ambulant; and 26 (9%) were paraplegic. Bladder dysfunction was present in 41 (14%) pre‐treatment. In the 303 evaluable participants, 212 (70%) had unfavourable primary tumour histologies, and 91 (30%) had favourable primaries for response to RT. These baseline characteristics were similar in the intervention arms. </p> </section> <section id="CD006716-sec-0084"> <p><b>1.2 Eight fractions "split‐course regimen" versus two fractions "short‐course regimen"</b></p> <p><a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>, in an earlier multi‐centre trial in Italy, randomised 300 participants with no indications for surgery and with a poor prognosis (as in <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>) to receive eight fractions: "split‐course regimen" (5 Gy x 3, 4 days rest; then 3 Gy x 5, to a total of 30 Gy in 2 weeks); or to two fractions: "short‐course regimen" (8 Gy, 6‐days rest, and then 8 Gy, to a total of 16 Gy in one week). RT was started within 24 hours of the radiologic diagnosis. The timing of intervention in relation to development of cord compression was not reported. Dexamethasone 8 mg twice daily was given to all participants and tapered after completion of RT. Parenteral 5‐hydroxytryptamine‐3 receptor antagonists were also given to those in whom radiation included the upper abdomen (60%). Here, too, assessments were done one month after the end of radiotherapy and follow‐up examinations were continued once a month for one year, and four times per year until death. The median follow‐up was 33 months (range: 4 to 61 months). </p> <p>As in <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>, in the majority (177 of 276 evaluable participants (64%)), the histology of the primary tumour was unfavourable, and 99 (36%) had favourable histological primary tumours. Of the 276 evaluable participants, 262 (95%) had back pain pre‐treatment; 184 (67%) were able to walk (107 (39%) without support and 77 (28%) with support); 75 (27%) were non‐ambulant; and 17 (6%) were paraplegic. Bladder dysfunction was present in 29 (11%) pre‐treatment. Baseline characteristics were similar in the intervention arms. </p> </section> </section> <section id="CD006716-sec-0085"> <h6 class="title">2. Different surgical approaches with radiotherapy compared to radiotherapy alone</h6> <section id="CD006716-sec-0086"> <p><b>2.1 Laminectomy with postoperative radiotherapy versus radiotherapy alone</b></p> <p><a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a> was the first randomised trial in people with MESCC and was conducted in two centres in the United States of America (USA). Twenty‐nine participants with haematologic and solid tumours, and a myelographic diagnosis of cord compression, were randomised to laminectomy and post‐operative radiotherapy or radiotherapy alone. Participants were followed up till death, but the average duration of follow‐up was not reported. Complete myelographic block (22/29) was significantly more common in the surgery group (15/16; 94%) than the RT group (7/13; 54%) and was a confounding factor that negatively influenced some outcomes. The authors emphasised the need to stratify patients by clinically significant prognostic factors in future studies. </p> </section> <section id="CD006716-sec-0087"> <p><b>2.2. Direct decompressive surgery and postoperative radiotherapy versus radiotherapy alone</b></p> <p><a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> was a randomised multicentric trial conducted in the USA. The trial recruited participants with an MRI diagnosis of a single area of MESCC, an expected survival of at least three months, and non‐radiosensitive primaries. Participants should not have been paraplegic for greater than 48 hours. Over one third of participants had spinal instability or pathologic spine fractures. One hundred and one participants were randomised to surgical decompression and postoperative radiotherapy (with stabilisation if instability was present); or to radiotherapy alone, 30 Gy in 10 fractions. All patients were given high‐dose dexamethasone 100 mg initially that was tapered until completion of radiotherapy. Ten patients from the radiotherapy arm crossed over to surgery because of deteriorating neurological status. After 10 years of recruitment, the study was stopped with 50% recruitment because results in the surgical arm were superior in an interim analysis with prespecified stopping rules. </p> </section> </section> <section id="CD006716-sec-0088"> <h6 class="title">3. High dose corticosteroids versus moderate dose steroids or no steroids (placebo)</h6> <p>Three trials (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>; <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a>; <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>) with participant numbers ranging from 20 to 57 assessed the role of corticosteroids in patients receiving conventional radiotherapy for MESCC. <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a> and <a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a> excluded haematologic malignancies. <a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a> and <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a> compared high‐dose boluses of dexamethasone of 96 mg to 100 mg, with moderate doses of 10 mg to 16 mg. <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a> compared a single dose of 100 mg dexamethasone with saline placebo. <a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a> administered omeprazole and nystatin as prophylaxis to all participants. </p> </section> </section> <section id="CD006716-sec-0089"> <h5 class="title">Outcomes</h5> <section id="CD006716-sec-0090"> <h6 class="title">Primary outcome</h6> <p><b>Ambulation</b> </p> <p>All trials reported ambulation as a primary outcome but used different criteria to define ambulation. <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> reported a participant as ambulant if he or she was able to take at least two steps with each foot (four steps in total) either unassisted or with use of a cane or walker at completion of radiotherapy. <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> and <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> used <a href="./references#CD006716-bbs2-0068" title="TomitaK , KawaharaN , KobayashiT , YoshidaA , MurakamiH , AkamaruT . Surgical strategy for spinal metastases. Spine2001;26(3):298‐306. ">Tomita 2001</a> grades for ambulation (group I – ability to walk without support; group II – ability to walk with support; group III – inability to walk; and group IV – paraplegic) where participants who were walking with or without support at one month were considered ambulant. The three corticosteroid studies measured ambulation in different ways and at different time points. <a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a> used different definitions of ambulation within the trial but did not provide these definitions in the trial report; the report also noted variability in ambulatory outcomes depending on the definition used. <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a> used five grades of ambulation, with Grade I (walking independently) and Grade II (walking with support) used to denote good ambulation compared to Grade III (walking not possible but both legs can be lifted from the bed), Grade IV (lifting of legs not possible but muscle contraction is present in legs), and Grade V (absence of muscle contractions in legs). <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a> defined ambulation (in a similar manner to <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>) as the ability to take steps (number not specified) alone, even if a cane or walker was required. </p> <p>Data were provided for proportions ambulant pre‐treatment and overall ambulatory rates after treatment in all trials. The proportions maintaining and regaining ambulation were reported in all trials except two (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>; <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>). </p> </section> <section id="CD006716-sec-0091"> <h6 class="title">Secondary outcomes</h6> <p>Survival: all trials reported survival except <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>. However, many did not report survival data in a form that could be analysed as they were reported as medians, or as the percentage probability of survival. </p> <p>Pain relief: five trials provided data on pain relief as reduction in analgesic and narcotic use or as proportions with pain reduction (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>; <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>; <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>; <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>). In the remaining trials this was not reported or was reported in a form that could not be used. </p> <p>Urinary incontinence: <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>, <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>, <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>, and <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a> also provided usable data on urinary continence. This was defined in two as not requiring a urinary catheter (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>). <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> reported the median duration of maintaining urinary continence, but not the proportions with urinary continence. </p> <p>Local recurrence: only two trials provided data on in‐field recurrences (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>). </p> <p>Adverse events: all trials provided data on adverse events though in some it was unclear if they were systematically ascertained. </p> <p>Quality of life: none of the trials reported this outcome.</p> <p>Participant or caregiver satisfaction: none of the trials reported this.</p> <p>Characteristics of participants who benefit from treatment: four trials provided this information (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>; <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>; <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>). </p> </section> </section> </section> <section id="CD006716-sec-0092"> <h4 class="title">Excluded studies</h4> <p>This update contains the references to, and reasons for exclusion of, eight studies (described in nine reports) in people with MESCC (see: <a href="./references#CD006716-bbs1-0002" title="">Excluded studies</a>). Only one was an RCT but the comparisons evaluated were not relevant to this review (<a href="./references#CD006716-bbs2-0010" title="HoldenL , LoblawA . Recombinant human erythropoietin (r‐HuEPO) in the prevention of neurologic sequelae from malignant spinal cord compression (MSCC): A multicenter, placebo‐controlled, phase 2 randomized study. Journal of Medical Imaging and Radiation Sciences. [Conference Abstract]2011;42(3):155. ">Holden 2011</a>). </p> <section id="CD006716-sec-0093"> <h5 class="title">Ongoing trials</h5> <p>The two ongoing trials (<a href="./references#CD006716-bbs2-0017" title="A randomised feasibility study of single fraction radiotherapy compared to multi‐fraction radiotherapy in patients with metastatic spinal cord compression. http://controlled‐trials.com, UK Clinical Trials Gateway. [CRUK‐UCL‐BRD‐07‐010; EU‐20863; NCT00727584] ">ISRCTN97555949</a> and <a href="./references#CD006716-bbs2-0018" title="A randomised phase III trial of two fractionation schemes in the treatment of malignant spinal cord compression (Spinal Cord Compression. ICORG 05‐03, V6). http://clinicaltrials.gov/show/NCT00968643. [CDR0000644307; EU‐20952; ICORG‐05‐03] ">NCT00968643</a>) identified by the 2008 search are still ongoing. <a href="./references#CD006716-bbs2-0017" title="A randomised feasibility study of single fraction radiotherapy compared to multi‐fraction radiotherapy in patients with metastatic spinal cord compression. http://controlled‐trials.com, UK Clinical Trials Gateway. [CRUK‐UCL‐BRD‐07‐010; EU‐20863; NCT00727584] ">ISRCTN97555949</a> is an RCT of single‐fraction radiotherapy compared to multi‐fraction radiotherapy in patients with metastatic spinal cord compression. Although scheduled for completion in August 2009, the contact investigator informed us that they expect to complete recruitment by the end of 2014. <a href="./references#CD006716-bbs2-0018" title="A randomised phase III trial of two fractionation schemes in the treatment of malignant spinal cord compression (Spinal Cord Compression. ICORG 05‐03, V6). http://clinicaltrials.gov/show/NCT00968643. [CDR0000644307; EU‐20952; ICORG‐05‐03] ">NCT00968643</a> is a randomised phase III trial of two fractionation schemes in the treatment of malignant spinal cord compression that is currently recruiting participants. They are described in more detail in <a href="./references#CD006716-sec-0179" title="">Characteristics of ongoing studies</a>. </p> </section> </section> </section> <section id="CD006716-sec-0094"> <h3 class="title">Risk of bias in included studies</h3> <p>The details of 'risk of bias' assessments are provided in the '<a href="./references#CD006716-sec-0176" title="">Characteristics of included studies</a>' table, and are summarised in <a href="#CD006716-fig-0002">Figure 2</a> and <a href="#CD006716-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD006716-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006716-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD006716-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006716-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD006716-sec-0095"> <h4 class="title">Allocation</h4> <p>All included studies were judged at low risk for selection bias except <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>, that was judged at high risk of selection bias since allocation concealment was not reported and baseline imbalances in prognostic variables were evident. </p> </section> <section id="CD006716-sec-0096"> <h4 class="title">Blinding</h4> <p>Because of the nature of the studies, blinding of clinicians and participants was not practical for the radiotherapy and surgical trials. <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a> and <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a> were judged at low risk of performance and detection bias while the remainder were judged at unclear risk on this domain (<a href="#CD006716-fig-0003">Figure 3</a>). </p> </section> <section id="CD006716-sec-0097"> <h4 class="title">Incomplete outcome data</h4> <p><a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a> was judged unclear for the risk of attrition bias for efficacy outcomes and at high risk of attrition bias for adverse events. <a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a> was judged unclear for the risk of attrition bias for reporting adverse events. </p> </section> <section id="CD006716-sec-0098"> <h4 class="title">Selective reporting</h4> <p>None of the trials were prospectively registered (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a> was retrospectively registered) and the trial protocols were not available for any trial. However, no evidence of selective reporting was detected. </p> </section> <section id="CD006716-sec-0099"> <h4 class="title">Other potential sources of bias</h4> <p><a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> was prematurely terminated for apparent benefit after only 50% recruitment had been achieved. This is often considered a source of bias, since such truncated RCTs are associated with greater effect sizes than RCTs not stopped early, with this difference being greatest in smaller studies (particularly those that have fewer than 200 events), and independent of the presence of statistical stopping rules, even if they were pre‐determined (<a href="./references#CD006716-bbs2-0020" title="BasslerD , BrielM , MontoriVM , LaneM , GlasziouP , ZhouQ , et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta‐regression analysis. JAMA2010;303(12):1180‐7. ">Bassler 2010</a>). However, following updated advice in <a href="./references#CD006716-bbs2-0034" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a> (Table 8.5b), we judged this trial as unclear for the risk of bias due to premature stopping. No other sources of bias were evident in any trial. </p> </section> </section> <section id="CD006716-sec-0100"> <h3 class="title" id="CD006716-sec-0100">Effects of interventions</h3> <p>See: <a href="./full#CD006716-tbl-0001"><b>Summary of findings for the main comparison</b> Single‐fraction radiotherapy (8 Gy) compared to short‐course radiotherapy (16 Gy in two fractions) for adults with metastatic extradural spinal cord compression</a>; <a href="./full#CD006716-tbl-0002"><b>Summary of findings 2</b> Split‐course radiotherapy (8 fractions, 30 Gy) compared to short‐course radiotherapy (2 fractions, 16 Gy) for adults with metastatic extradural spinal cord compression</a>; <a href="./full#CD006716-tbl-0003"><b>Summary of findings 3</b> Laminectomy plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</a>; <a href="./full#CD006716-tbl-0004"><b>Summary of findings 4</b> Decompressive surgery plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</a>; <a href="./full#CD006716-tbl-0005"><b>Summary of findings 5</b> High‐dose corticosteroids compared to moderate‐dose or no corticosteroids for adults with metastatic extradural spinal cord compression</a> </p> <section id="CD006716-sec-0101"> <h4 class="title">1. Different radiotherapy schedules</h4> <section id="CD006716-sec-0102"> <h5 class="title">1.1 Single‐fraction radiotherapy (8 Gy) versus a short course of radiotherapy (two fractions of 8 Gy) </h5> <p><a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> compared a single dose of radiotherapy (8 Gy) versus a short course of radiotherapy (8 Gy × 2, given as 8 Gy, 6 days rest, and then 8 Gy, to a total dose of 16 Gy over one week) in 327 randomised participants with poor prognosis, of whom 303 were evaluable. Parenteral dexamethasone (8 mg twice daily) was administered from the first day of clinical‐radiologic diagnosis for 4 to 5 days. Follow‐up was for a median duration of 31 months (range four to 58 months). </p> <p>The trial was powered to demonstrate equivalence in the response rate one month after treatment with the two regimens. The response rate was separately evaluated for ambulatory status (maintaining or regaining ambulation), urinary continence (not requiring a catheter), and back pain (not requiring a narcotic). The sample size ensured an 80% probability to detect equivalence in these response rates with a two‐sided precision of 15% if the response rate was similar and approximately 70%. </p> <p>Since the data for this comparison comes from only a single study, we were not able to perform a meta‐analysis for any of the outcomes assessed. </p> <section id="CD006716-sec-0103"> <h6 class="title">1.1.1 Ambulation</h6> <p>Overall ambulatory rates post‐treatment were 65% with single‐dose RT and 69% with short‐course RT, and did not significantly differ (303 participants). Single‐dose RT and short‐course RT also did not differ significantly in the proportions who maintained ambulation (88% versus 90%; 199 participants), nor in the proportions who regained ambulation post‐RT (16% versus 26%; 104 participants). The difference in ambulatory rates was within 15% (7% for overall ambulation; 2% for maintaining ambulation; and 10% for regaining ambulation), meeting pre‐set criteria to demonstrate equivalence in enhancing ambulation with the two RT schedules. </p> <p><b>1.1.2 Other outcomes</b> </p> <p>The median survival was four months in both intervention arms (excluding three early deaths and 21 lost to follow‐up). </p> <p>Reduction in analgesic or narcotic use was seen in both treatment arms (34% with single‐dose RT and 40% with short‐course RT) and did not significantly differ between the RT regimens (271 participants). The difference in response rate for pain of 6% was within the bounds pre‐set to demonstrate equivalence. </p> <p>Similar proportions (90% given single‐dose RT versus 87% given short‐course RT) had urinary continence after treatment (303 participants), with the difference of 3% again demonstrating equivalence in response with the two RT schedules . </p> <p>Local recurrence was diagnosed by MRI in people with symptomatic progression in 4% of patients, at a median interval between the end of the first RT and diagnosis of 8 months (range two to 31 months). In‐field recurrences were higher in the single‐fraction arm (6% versus 3%), but the numbers with in‐field recurrences were too few to rule out random error. Seven of the 13 with in‐field recurrences were re‐irradiated as decided by their treating clinicians and outside of the trial protocol. Those ambulant at the time of recurrence survived longer after irradiation compared to those non‐ambulant; and maintained their ability to walk till the time of death. None who were non‐ambulant at the time of recurrence regained ambulatory status after re‐irradiation. Median survival after irradiation was six months (range: 1 to 13 months). None developed serious adverse events or radiation‐induced myelopathy. In those re‐irradiated, the cumulative BED Gy<sub>2</sub> (Biologically Effective Dose with an α/β ratio of 2 Gy) did not exceed 120 Gy<sub>2</sub>. </p> </section> <section id="CD006716-sec-0104"> <h6 class="title">1.1.3 Adverse events</h6> </section> <section id="CD006716-sec-0105"> <h6 class="title">Early</h6> <p>Gastrointestinal adverse events of Grade 3 severity was seen only in three people given short‐course RT. Less severe grades of oesophagitis, diarrhoea, nausea and vomiting were not significantly different with both RT regimens. No participant developed serious adverse events. </p> </section> <section id="CD006716-sec-0106"> <h6 class="title">Late</h6> <p>No radiation myelopathy was noted over a median follow‐up of 31 months (range 4 to 58 months). </p> </section> <section id="CD006716-sec-0107"> <h6 class="title">1,1.4. Outcomes not reported</h6> <p>Quality of life, and participant and caregiver satisfaction were not reported.</p> </section> <section id="CD006716-sec-0108"> <h6 class="title">1.1.5. Subgroup analysis</h6> <p>Although meta‐analysis was not possible, and the planned subgroup analyses to investigate heterogeneity were not indicated, subgroup analyses in <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> indicated that the duration of ambulation after treatment was influenced by tumour histology and was significantly longer with favourable histologies (median duration 11 months) than with unfavourable histologies (four months). </p> <p>Survival was also associated with pre‐treatment and post‐treatment ambulatory status; median survival was five months and two months for pre‐treatment ambulant and non‐ambulant patients respectively, (P = 0.001); and six months and one month for post‐treatment ambulant and no‐ambulant patients respectively (P &lt; 0.001). The median survival was also influenced by tumour histology and was 9.5 months for favourable cancers and three months for unfavourable ones (P &lt; 0.001). </p> <p>Ambulatory outcomes were also better in those ambulant pre‐treatment, the majority of whom maintained ambulatory status (88% and 90% with single dose and two doses respectively), while only 16% and 28% of those non‐ambulant pre‐treatment regained ambulation with the two RT regimens. </p> <p>Outcomes for those with and without visceral metastases were not available. Vertebral instability and bony impingement were exclusion criteria in this trial. All participants were detected to have MESCC after active screening by MRI or CT and the results of this trial pertain to those who are actively screened to enable an early diagnosis of cord compression and early RT within 24/48 hours after diagnosis. </p> </section> <section id="CD006716-sec-0109"> <h6 class="title">1.1.6.Sensitivity analysis</h6> <p>Overall loss to follow‐up was only 7%, and there was no differential loss in the two arms. Attrition was considered unlikely to have influenced outcome estimates. </p> </section> </section> <section id="CD006716-sec-0110"> <h5 class="title">1.2 Split‐course (eight fractions) radiotherapy versus short‐course (two fractions) radiotherapy </h5> <p><a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> was also powered to detect equivalence in response rates for the outcomes of ambulation, urinary continence and pain reduction based on narcotic use, using the same assumptions (80% power to detect equivalence in response rates with a precision of 15% if the response rates were roughly similar and around 70%) as described above in <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>. </p> <p>Data were from only one trial and we were unable to perform a meta‐analysis for any outcome. The results are summarised below and there were no statistically significant differences between the two arms for any of the outcomes analysed. </p> <section id="CD006716-sec-0111"> <h6 class="title">1.2.1 Ambulation</h6> <p>Overall ambulatory rates were 70% for eight fractions versus 68% for two fractions and did not significantly differ (276 participants). There were no significant differences in the proportions who maintained ambulation (91% versus 89%; 184 participants), or who regained ambulation (28% versus 29%; 92 participants). The median duration of ambulation (excluding 17 early deaths) was 3.5 months in both arms. The difference in ambulatory rates with the two RT schedules were less than 15% (3% for overall ambulation and maintaining ambulation, and 1% for regaining ambulation), demonstrating equivalence in enhancing ambulation with split‐course (eight fractions) and short‐course (two fractions) radiotherapy. </p> </section> <section id="CD006716-sec-0112"> <h6 class="title">1.2.2 Other outcomes</h6> <p>The median survival was four months in both intervention arms (excluding 17 early deaths). </p> <p>The proportion of participants with reduction in the use of analgesics and narcotics was not significantly different (49% versus 38%; 262 participants); and the difference in response rates (9%) was within the pre‐set limits to demonstrate equivalence in response rates between the split‐course and short‐course RT regimens. </p> <p>The overall proportion of participants with urinary continence after treatment was also not significantly different (87% versus 90%; 275 participants) for split‐course versus short‐course RT, and the difference in urinary continence rates (3%) again demonstrated equivalence. </p> <p>Local recurrence was diagnosed on MRI in 5/142 (4%) given the short‐course RT regimen and none of 134 given the longer‐course RT regimen, but this difference was not statistically significant given the small number of local recurrences. The five with recurrences were re‐irradiated with different RT schedules at the discretion of their treating clinicians and outside the trial protocol. The two non‐ambulant before irradiation continued to be non‐ambulant till death (three and four months later) while the three ambulant maintained ambulation till death in two (one and seven months later) and at 20 months' follow‐up in the third. Radiation‐induced myelopathy was not detected in any of the five. In this trial, as in <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>, the cumulative BED Gy<sub>2</sub> did not exceed 120 Gy<sub>2</sub> in those with in‐field recurrences who were irradiated. </p> </section> <section id="CD006716-sec-0113"> <h6 class="title">1.2.3 Adverse effects</h6> </section> <section id="CD006716-sec-0114"> <h6 class="title">Early</h6> <p>Grade 3 acute gastrointestinal mucositis attributable to radiation was reported in 4% of patients who had eight fractions of radiotherapy and in 2% of those who had two fractions of radiotherapy; 6/276 (2%) of participants had Grade 3 vomiting, and 5/276 (2%) had Grade 3 nausea; the incidence was similar with both the RT regimens. No other serious adverse events were noted. </p> </section> <section id="CD006716-sec-0115"> <h6 class="title">Late</h6> <p>There was no documented instance of late radiation myelopathy over a median follow‐up of 33 months (range: 4 to 61 months). </p> </section> <section id="CD006716-sec-0116"> <h6 class="title">1.2.4 Outcomes not reported</h6> <p>Survival rates, quality of life, and participant and caregiver satisfaction were not reported. </p> </section> <section id="CD006716-sec-0117"> <h6 class="title">1.2.5 Subgroup analysis</h6> <p>Data were from only a single trial but subgroup analyses in <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> revealed that the duration of ambulation post‐treatment was influenced by tumour histology (six months with favourable histologies and three months for unfavourable histologies). Survival was also significantly correlated with ambulant status. Median survival was five months for those ambulant pre‐treatment and three months for those non‐ambulant pre‐treatment; median survival was five months for those ambulant after treatment and two months for those non‐ambulant post‐treatment. Median survival was also influenced by tumour histology and was significantly longer (six months) with favourable histologies compared to unfavourable histologies (three months). </p> <p>Ambulatory outcomes were also better in those ambulant pre‐treatment, the majority of whom maintained ambulatory status (91% and 89% with eight doses and two doses respectively), while only 28% and 29% of those non‐ambulant pre‐treatment regained ambulation with the two RT regimens. </p> <p>Outcomes for those with and without visceral metastases were not available. Vertebral instability and bony impingement were exclusion criteria in this trial. As in <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>, participants in <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> with a primary tumour and with local or radicular pain even in the absence of neurological symptoms were screened actively with MRI or CT to establish an early diagnosis of cord compression, and early institution of RT within 24 hours of the diagnosis. </p> <p><b>1.2.5 Sensitivity analyses</b> </p> <p><a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> reported that the 24 patients excluded from analyses (those lost to follow‐up or who experienced early deaths) were well balanced between the two arms and an intent‐to‐treat analysis did not significantly alter the results. </p> </section> </section> </section> <section id="CD006716-sec-0118"> <h4 class="title">2. Different surgical procedures plus radiotherapy compared to radiotherapy alone</h4> <section id="CD006716-sec-0119"> <h5 class="title">2.1 Laminectomy plus radiotherapy versus radiotherapy alone</h5> <p>The results for laminectomy plus radiotherapy versus radiotherapy alone are from a single trial with 29 participants and we were unable to perform a meta‐analysis for any outcome (<a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>). The results for laminectomy plus RT were not significantly different from RT alone for the primary and secondary outcomes. </p> <section id="CD006716-sec-0120"> <h6 class="title">2.1.1 Ambulation</h6> <p>Overall ambulatory rates for laminectomy versus radiotherapy were 44% and 54% immediately after treatment; and 37% versus 39% at four months; and did not significantly differ at both time‐points. Half of laminectomy patients versus all radiotherapy patients maintained ambulation; while 40% of surgical patients and 25% of radiotherapy patients regained ambulation immediately after treatment; these differences were also not statistically significant. </p> </section> <section id="CD006716-sec-0121"> <h6 class="title">2.1.2 Other outcomes</h6> <p>Short‐term survival (100% versus 77%; 29 participants) and intermediate‐term survival (56% versus 46%; 29 participants) were not significantly different with laminectomy or radiation. Reduction in analgesic use in those with pain pre‐treatment (50% versus 57%; 26 participants); and urinary continence in the short term (44% versus 54%; 29 participants) or in the intermediate term in survivors (67% versus 100%; 15 participants) also did not significantly differ between the two intervention arms. </p> </section> <section id="CD006716-sec-0122"> <h6 class="title">2.1.3 Adverse effects</h6> <p>There were no surgery‐ or radiotherapy‐related complications reported.</p> </section> <section id="CD006716-sec-0123"> <h6 class="title">2.1.4 Outcomes not reported</h6> <p>Local recurrence, quality of life, participant and caregiver satisfaction were not assessed. </p> </section> <section id="CD006716-sec-0124"> <h6 class="title">2.1.5 Subgroup analysis</h6> <p>Although data were only from a single trial, a post‐hoc subgroup analysis in <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a> revealed that those with a complete myelographic block fared significantly poorer than those with an incomplete block for ambulation and sphincter function immediately after treatment; with this trend persisting in survivors four months after treatment. </p> <p><b>2.1.6 Sensitivity analysis</b> </p> <p>None of the planned sensitivity analyses were relevant in this single trial.</p> </section> </section> <section id="CD006716-sec-0125"> <h5 class="title">2.2. Direct decompressive surgery with radiotherapy versus radiotherapy</h5> <p><a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> recruited 101 participants with an MRI diagnosis of a single area of MESCC, an expected survival of at least three months, and non‐radiosensitive primaries. All had a duration of paraplegia less than 48 hours; and were immediately randomised to emergency surgical decompression and postoperative radiotherapy (with stabilisation if instability was present) or radiotherapy alone (30 Gy in 10 fractions). All patients were given high‐dose dexamethasone, 100 mg, initially that was tapered by completion of radiotherapy. We were unable to perform a meta‐analysis since the data for all outcomes were only from one trial. </p> <section id="CD006716-sec-0126"> <h6 class="title">2.2.1 Ambulation</h6> <p>The overall ambulatory rates and the proportion of participants maintaining or regaining ambulation were significantly better in the surgery plus radiotherapy group. At completion of treatment, overall ambulatory rates were 84% versus 57% (RR 1.48, 95% CI 1.16 to 1.90; 101 participants). Of them, 94% versus 74% previously ambulant patients maintained ambulation (RR 1.27, 95% CI 1.02 to 1.57; 69 participants). Of those in the decompressive surgery followed by RT arm, 63% versus 19% given RT alone who were previously non‐ambulant regained ambulation; (RR 3.33, 95% CI 1.12 to 9.90; 32 participants). The median duration of ambulation also significantly favoured surgical decompression (122 days versus 13 days; P = 0.003). For maintaining ambulation, medians were 153 days versus 54 days; and for regaining ambulation 59 versus 0 days in the surgery and radiotherapy arms respectively. </p> </section> <section id="CD006716-sec-0127"> <h6 class="title">2.2.2 Other outcomes</h6> <p>Of the 101 participants, similar proportions (94% after surgical decompression and 86% after RT) were alive at one month. However, median survival was statistically significantly longer for surgery plus radiotherapy compared to RT alone (126 days versus 100 days; P = 0.033). </p> <p>The authors reported that the median daily morphine equivalent dose was significantly lower in the surgery plus RT arm than in the RT arm (0.4 mg, range 0 mg to 60 mg versus 4.8 mg, range 0 mg to 200 mg; P = 0.002). </p> <p>The authors also reported that urinary continence was maintained significantly longer in those who were surgically decompressed and given RT compared to those given RT alone (after surgery plus RT the median duration for maintaining continence was 156 days compared to 17 days with RT; P = 0.016). </p> </section> <section id="CD006716-sec-0128"> <h6 class="title">2.2.3 Adverse events</h6> <p>Surgery did not prolong hospitalisation significantly compared to RT. Extended hospital stays (greater than 20 days) occurred in seven patients in those given surgery plus RT compared to 11 given RT alone. Ten patients (20%) in the RT group who had a substantial decline in motor strength during radiotherapy crossed over to receive surgery. Four of them (40%) had surgical complications; three had wound infections and one had a failure of spinal ﬁxation that required additional surgery. </p> </section> <section id="CD006716-sec-0129"> <h6 class="title">2.2.4 Outcomes not reported</h6> <p>Quality of life, and participant and care‐giver satisfaction were not assessed. Local recurrence, participant‐rated pain relief, adverse effects, dichotomous data for analgesic reduction and urinary continence were not reported. </p> </section> <section id="CD006716-sec-0130"> <h6 class="title">2.2.5 Subgroup analysis</h6> <p>Although data were from a single trial, multivariate analysis in <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> showed surgery, Frankel score, and breast primary tumour to be associated with longer ambulatory times. In a secondary data analysis of prognostic factors using multivariate modelling and Kaplan‐Meier curves for stratified treatment groups from this trial, there was no difference in outcome between treatments for patients older than 65 years of age; and the benefits for decompressive surgery were apparent for ambulation and survival only in those less than 65 years of age (<a href="./references#CD006716-bbs2-0021" title="ChiJH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?: results from a randomized clinical trial. Spine (Phila Pa 1976).2009;34(5):431‐5. ">Chi 2009</a>). </p> <p><b>2.2.6 Sensitivity analysis</b> </p> <p>Attirition was negligible and hence the planned sensitivity analysis was not undertaken.</p> </section> </section> <section id="CD006716-sec-0131"> <h5 class="title">3. High dose corticosteroids versus no or moderate dose corticosteroids</h5> <section id="CD006716-sec-0132"> <h6 class="title">3.1 Ambulation</h6> <p>Three small trials did not show significant benefit for ambulation with high‐dose corticosteroids compared to no steroids or to moderate‐dose steroids given as adjuvant to conventional doses of RT (60% versus 55%; 3 RCTs, 105 participants; <a href="./references#CD006716-fig-0005" title="">Analysis 1.1</a>) (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>; <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a>; <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>). In <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a>, the proportions maintaining ambulation (100% versus 90%) and regaining ambulation (50% versus 18%) were not statistically significantly different between high‐dose steroids versus no steroids (1 RCT, 57 participants). </p> </section> <section id="CD006716-sec-0133"> <h6 class="title">3.2 Other outcomes</h6> <p>No significant difference was seen between high‐dose versus no corticosteroids for two‐year survival (11% versus 10%, 1 RCT, 57 participants); or versus moderate‐dose steroids for pain reduction (78% versus 91%; 1 RCT, 25 participants); or for urinary continence (63% versus 53%; 1 RCT, 34 participants). </p> </section> <section id="CD006716-sec-0134"> <h6 class="title">3.3 Adverse effects</h6> <p>There was a significant increase in the incidence of serious drug‐related adverse effects such as perforated gastric ulcer, psychoses and deaths due to infection in those who received high‐dose corticosteroids. Seventeen percent of this group developed serious adverse effects as compared to 0% of those who received moderate‐ or low‐dose corticosteroids (RR 8.02, 95% CI 1.03 to 62.37; two RCTs, 77 participants; <a href="./references#CD006716-fig-0006" title="">Analysis 1.2</a>; <a href="#CD006716-fig-0004">Figure 4</a>) </p> <div class="figure" id="CD006716-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 High dose versus no or moderate dose corticosteroids, outcome: 1.2 Serious drug related adverse effects." data-id="CD006716-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 High dose versus no or moderate dose corticosteroids, outcome: 1.2 Serious drug related adverse effects. </p> </div> </div> </div> </section> <section id="CD006716-sec-0135"> <h6 class="title">3.4 Outcomes not reported</h6> <p>Local recurrence, quality of life, and participant‐rated or caregiver‐rated satisfaction were not reported in any of the three corticosteroid trials. </p> </section> <section id="CD006716-sec-0136"> <h6 class="title">3.5 Subgroup analysis</h6> <p>Data were not heterogenous where meta‐analysis was possible, and subgroup analyses were therefore not indicated. Favourable histologies (breast and prostate cancer) and baseline ambulant status predicted longer survival with high‐ and low‐dose steroids in <a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>,. Those with breast cancers also had significantly better ambulatory outcomes than those with other primary tumours in <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a>, </p> <p><b>3.5 Sensitivy analysis</b> </p> <p><a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a> was judged at high risk for attrition bias for adverse events but did not contribute data to the meta‐analysis for adverse events; hence no sensitivity analysis was indicated. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006716-sec-0137" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006716-sec-0137"></div> <section id="CD006716-sec-0138"> <h3 class="title" id="CD006716-sec-0138">Summary of main results</h3> <p>Although metastatic extradural spinal cord compression (MESCC) is a common and distressing problem in many people with cancer, there is limited evidence from RCTs to inform optimal treatment. We found only seven eligible trials with a total of 876 (723 evaluable) participants that compared three different sets of comparisons in adults with MESCC: different radiotherapy schedules; surgery plus RT versus RT; and high‐dose steroids versus moderate‐dose steroids versus no steroids. Meta‐analysis was not possible for most outcomes. </p> <section id="CD006716-sec-0139"> <h4 class="title">1. Radiotherapy doses and schedules</h4> <p>Radiotherapy (combined with corticosteroids) is the most widely used treatment for cord compression, and was part of the treatment protocol in all the seven trials reviewed. Only <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> and <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> directly compared the effects of different radiotherapy fractionation schedules combined with steroids in people with MESCC with a poor prognosis. </p> <p>These two Italian trials were powered to demonstrate equivalence and showed that in patients with MESCC with no indications for primary surgery and an estimated survival of six months or less, the short‐term results were similar with a single dose of 8 Gray (Gy) to two fractions of 8 Gy given over a week (<i>moderate quality evidence</i>; <a href="./full#CD006716-tbl-0001">summary of findings Table for the main comparison</a>); as were two fractions of 8 Gy compared to eight fractions (30 Gy) of RT (<i>moderate quality evidence</i>; <a href="./full#CD006716-tbl-0002">summary of findings Table 2</a>). In both trials, those who were ambulant pre‐treatment and who had favourable histologies were ambulant longer and survived longer post‐treatment than those not ambulant pre‐treatment or with unfavourable histologies. </p> <p>With the three radiotherapy fractionation regimens, around 90% of ambulant patients maintained ambulation; around 3% had a documented overall in‐field recurrence rate; median survival was four months; and toxicity was minimal. This suggests that shorter courses of radiotherapy are probably justified in patients with MESCC and a poor prognosis, who constitute a significant proportion of the MESCC population, particularly in many resource‐constrained settings. </p> <p>The incidence of in‐ﬁeld recurrences with single‐dose RT was 6%. With two doses of RT recurrences ranged from 2.5% to 3.5% in the two trials where short‐course RT was a comparator, and was 0% with eight doses. Though not statistically significant due to the small number of recurrences, these differences in recurrence rates suggest that people with an expected survival more than three to six months who decline, or are not suitable candidates for surgical interventions, should perhaps be offered courses longer than a single dose or even two doses of RT, if local tumour recurrence is to be delayed or averted. Further comparative studies with larger samples would be required to confirm this impression. Data from a prospective non‐randomised study also suggests that local control is poorer (61% versus 81%) in those given short courses of RT (8 Gy or 20 Gy in five fractions) compared to longer courses of RT (37.7 Gy in 15 fractions or 40 Gy in 20 fractions) (<a href="./references#CD006716-bbs2-0057" title="RadesD , LangeM , VeningaT , StalpersLJ , BajrovicA , AdamietzIA , et al. Final results of a prospective study comparing the local control of short‐course and long‐course radiotherapy for metastatic spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2011;79(2):524‐30. ">Rades 2011a</a>). In those who develop recurrences, re‐irradiation may be considered, particularly in those ambulant; while ensuring that the cumulative BED does not exceed 120Gy<sub>2</sub> in order to reduce the chances of developing radiation‐induced myelopathy (<a href="./references#CD006716-bbs2-0054" title="RadesD , RudatV , VeningaT , StalpersLJ , HoskinPJ , SchildSE . Prognostic factors for functional outcome and survival after re‐irradiation for in‐ﬁeld recurrences of metastatic spinal cord compression. Cancer2008;113:1090‐6. ">Rades 2008</a>). </p> <p>The results in non‐ambulant patients with the short‐course (16 Gy in two fractions) or the split‐course ( 30 Gy in eight fractions) RT regimens were similar to rates in reports from non‐randomised prospective studies with 28% to 29% of non‐ambulant patients regaining ambulation (<a href="./references#CD006716-bbs2-0057" title="RadesD , LangeM , VeningaT , StalpersLJ , BajrovicA , AdamietzIA , et al. Final results of a prospective study comparing the local control of short‐course and long‐course radiotherapy for metastatic spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2011;79(2):524‐30. ">Rades 2011a</a>). Though the results in non‐ambulant participants in the comparison of short‐course RT with a single dose of 8 Gy did not differ significantly, the smaller proportion regaining ambulation with a single dose (9/55; 16%) in <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> is worrying. It is possible that the proportions that will regain ambulation with single‐dose RT may be similar to that with a short course or with longer RT courses, since the 95% CI for this estimate in <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> ranged from 9% to 29%. This would need confirmation in future trials; until which time, non‐ambulant people with MESCC who are considered for RT could be offered two or more doses of treatment. </p> <p>We did not find trials comparing different radiotherapy doses, schedules or techniques in people with MESCC and a good prognosis; and no conclusions can be drawn regarding the optimal radiotherapy dose or schedules in this population. </p> </section> <section id="CD006716-sec-0140"> <h4 class="title">2. Surgery plus radiotherapy versus radiotherapy alone</h4> <section id="CD006716-sec-0141"> <h5 class="title">Laminectomy followed by radiotherapy</h5> <p>Data from <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a> comparing outcomes in 16 people with a single lesion, no prior RT and who were fit to undergo surgery indicate that ambulation and survival at four months and urinary continence one month after treatment may not differ significantly with the addition of laminectomy prior to RT compared to RT alone (<i>low quality evidence</i>; <a href="./full#CD006716-tbl-0003">summary of findings Table 3</a>). Laminectomy for a ventrally located tumour is undesirable as direct decompression of the cord through removal of the compressive element is not achieved. Moreover, removal of the laminae and posterior ligaments of the spine in the setting of vertebral body disease quite often further destabilises the spine (<a href="./references#CD006716-bbs2-0039" title="KlimoP , ThompsonCJ , KestleJRW , SchmidtMHS . A meta‐analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro‐oncology2005;7(1):64‐76. ">Klimo 2005</a>). In two separate retrospective matched pair analyses of people with radiosensitive and radio‐resistant tumours, outcomes with laminectomy were not different to radiation alone (<a href="./references#CD006716-bbs2-0056" title="RadesD , HuttenlocherS , DunstJ , BajrovicA , KarstensJH , RudatV , et al. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. Journal of Clinical Oncology2010;28(22):3597‐604. ">Rades 2010b</a>); or were poorer than with radiotherapy (<a href="./references#CD006716-bbs2-0058" title="RadesD , HuttenlocherS , BajrovicA , KarstensJH , AdamietzIA , KazicN , et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. International Journal of Radiation Oncology, Biology, Physics2011;81(5):e861‐8. ">Rades 2011b</a>). Thus, though we are uncertain about the results of <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>, they are indicative of the lack of benefit expected with laminectomy and RT without spinal stabilisation compared to RT alone in metastatic spine disease. </p> </section> <section id="CD006716-sec-0142"> <h5 class="title">Direct decompressive surgical resection followed by radiotherapy</h5> <p>Progress in spine surgery, particularly with regard to sophisticated instrumentation and ventral approaches through the neck, thorax and abdomen, provides an opportunity for direct decompression of the cord and stabilisation of the spine. In <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> surgery was undertaken by experienced teams and was tailored to the location of the compression: that is, a ventral approach was employed for vertebral body disease, a lateral approach for predominantly laterally located compression and a posterior approach when the posterior elements were primarily involved. When required the spines were fixed using bone grafts and instrumentation. </p> <p>The results of <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> suggest that surgery may result in an incremental benefit of 27% in short‐term ambulatory rates compared to RT, in selected people with MESCC. For those regaining ambulation this benefit may be as much as 43%. With ambulation as a primary endpoint, <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> reported that 63% of non‐ambulant patients regained the ability to walk with surgery and radiotherapy as compared with only 19% in those receiving radiotherapy alone. Median survival was short in both treatment arms although statistically significantly longer in the surgery group versus radiotherapy alone. However, the overall quality of the evidence was graded as <i>low quality,</i> with full confidence in these estimates limited by the highly selected sample that was biased in favour of better outcomes in those undergoing decompression, and by the evidence for this intervention limited to one trial from a high‐income country that was stopped prematurely for perceived benefit. </p> <p><a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> acknowledges the restrictive selection criteria used in the trial and partly concedes that the results do not apply to the entire MESCC population. Subsequently the same group performed a secondary analysis of their data, stratifying patients into two groups based on age greater or less than 65. They concluded that patients over 65 years of age did not benefit from surgery, in terms of ambulation or survival (<a href="./references#CD006716-bbs2-0021" title="ChiJH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?: results from a randomized clinical trial. Spine (Phila Pa 1976).2009;34(5):431‐5. ">Chi 2009</a>). This conclusion is supported by <a href="./references#CD006716-bbs2-0059" title="RadesD , HuttenlocherS , EversJN , BajrovicA , KarstensJH , RudatV , et al. Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?. Strahlentherapie und Onkologie2012;188(5):424‐30. ">Rades 2012</a>, an independent matched‐pair analysis where data from 42 elderly people over 65 years of age from Europe offered surgery plus radiotherapy were retrospectively matched 1:2 to 84 people given radiotherapy alone for 10 potential prognostic factors and compared regarding motor function, local control, and survival. Additional matched‐pair analyses were performed for the subgroups of patients receiving direct decompressive surgery plus stabilisation of involved vertebrae (N = 81) and receiving laminectomy alone (N = 45). <a href="./references#CD006716-bbs2-0059" title="RadesD , HuttenlocherS , EversJN , BajrovicA , KarstensJH , RudatV , et al. Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?. Strahlentherapie und Onkologie2012;188(5):424‐30. ">Rades 2012</a> concluded that elderly people with MSCC did not benefit from surgery (decompressive surgery plus stabilisation or laminectomy) in addition to radiotherapy for functional outcomes, local control, or survival. </p> <p>We feel that the case for the routine use of direct decompressive surgery in patients with good neurological function and stable spines is not established based on current evidence. We suggest that in a patient with localised cord compression, clinicians need to consider the following questions: </p> <p> <ol id="CD006716-list-0013"> <li> <p>Are there prognostic features to suggest that the patient would have poor ambulatory outcomes with radiotherapy? </p> </li> <li> <p>Will the patient survive long enough to benefit from major surgery?</p> </li> </ol> </p> <p>In summary, the evidence from this review indicates that non‐ambulant adults with MESCC below 65 years of age, with an onset of paraplegia less than 48 hours, a single site of compression, radio‐resistant primary tumours, and an expected survival of more than three months, may benefit more from decompressive surgery followed by radiotherapy compared to radiotherapy alone. Radiotherapy alone may suffice for many ambulant patients with stable spines and radiosensitive tumours, while decompressive surgery followed by RT may be offered as first‐line therapy in those ambulant patients with factors predicting a poor outcome with radiotherapy and with good predicted survivals. </p> </section> </section> <section id="CD006716-sec-0143"> <h4 class="title">3. High dose corticosteroids versus no or moderate dose corticosteroids</h4> <p>Although corticosteroids have been used in the treatment of MESCC for many years, we found only three small trials that were inadequately powered to determine clinical benefit and optimal dosage (<a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a>; <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a>; <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>). No significant differences in ambulation, survival, and urinary continence, or for pain reduction were seen with high‐dose steroids compared to moderate‐dose or no steroids (<i>low quality evidence</i> ). However, high‐dose corticosteroids were associated with serious drug‐related adverse effects (<i>moderate quality evidence</i>; <a href="./full#CD006716-tbl-0005">summary of findings Table 5</a>). </p> <p>Considering the widespread clinical use of corticosteroids in MESCC, it is unlikely that a trial comparing corticosteroids to placebo will be undertaken in the future; but the serious adverse effects reported with high‐dose steroids should be noted. </p> </section> <section id="CD006716-sec-0144"> <h4 class="title">Adverse effects</h4> <p>One of our secondary objectives was to compare the adverse effects between different interventions but these were not always systematically recorded or graded. Serious adverse effects were infrequent in both arms of the <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> and <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> studies evaluating radiotherapy schedules. <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> reported more adverse effects in patients who had preoperative rather than postoperative radiotherapy after surgical decompression. In the corticosteroid dose comparison trials, serious gastrointestinal, infectious and central nervous system adverse effects were reported in 15% to 22% of participants receiving high‐dose corticosteroids. </p> </section> </section> <section id="CD006716-sec-0145"> <h3 class="title" id="CD006716-sec-0145">Overall completeness and applicability of evidence</h3> <section id="CD006716-sec-0146"> <h4 class="title">Completeness</h4> <p>We had planned to evaluate radiotherapy schedules, surgical interventions and adjunctive therapies. However, high‐dose corticosteroids versus moderate‐dose corticosteroids versus no corticosteroids was the only comparison for which there was more than one trial to allow meta‐analysis. We did not find trials eligible for inclusion that evaluated corticosteroid doses intermediate between 16 mg to 20 mg and 96 mg to 100 mg, or that evaluated the optimal duration of steroid therapy. We also found no trials comparing different doses of radiotherapy in people with MESCC with a good prognosis; nor did we find trials evaluating the role of decompressive surgery in health care settings outside that in a high‐income country. Trials evaluating newer treatment modalities such as minimally invasive surgical techniques, intensity modulated RT, and radiosurgery in MESCC were also not available for inclusion. The modern management of MESCC involves a variety of interventions, and a multidisciplinary approach; but trials that included education, rehabilitation, screening and supportive care as components of the interventions used were also lacking. Although we had not specified these in our search terms, our broad search strategy should have detected such RCTs. </p> <p>We assessed different comparisons in a heterogeneous population of adult patients with MESCC. Many of the trials included here had small numbers of participants making it difficult to draw precise or firm conclusions. Nor can our conclusions apply to all subgroups: patients with haematologic tumours, post‐RT recurrences, or paraplegia longer than 48 hours constituted a very small (or undeterminable) proportion of participants in the trials included in this review. </p> <p>Clinically important outcomes such as patient‐reported pain relief, satisfaction with treatment, and quality of life were not assessed in the included studies, and survival rates were not always adequately reported. Local recurrence was not reported in any of the trials apart from those evaluating different radiotherapy schedules. Not all reported data could be reliably used for analysis, for example when results are reported as medians, or as percentage probability of survival. </p> <p>The body of evidence to date is therefore incomplete to fully answer questions of current clinical relevance to the optimal management of people with MESCC. </p> </section> <section id="CD006716-sec-0147"> <h4 class="title">Applicability</h4> <p>Differences in inclusion criteria, and in the definition of ambulation used in the studies limit the applicability of the results of this review to clinical settings. Evidence for the superiority of surgical decompression over radiotherapy in <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>; and the equivalence of single dose over two doses in <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> and of two doses and eight doses of radiotherapy in <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> were from trials done in high‐income countries. The early detection of MESCC and the early institution of interventions that were critical in achieving the high response rates seen in these trials may not always be possible in many resource‐constrained settings, </p> <section id="CD006716-sec-0148"> <h5 class="title">Differences in inclusion criteria</h5> <p>Within the seven trials inclusion criteria varied and while <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> and <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> recruited patients with a poor prognosis, <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> required an estimated survival of at least three months. <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>, and <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> excluded patients with spinal instability but such patients comprised over a third of the <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> population. While <a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006,</a><a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> and <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a> excluded radiosensitive tumours other trials included haematologic and germ cell tumours (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>; <a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a>; <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>). <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> also excluded patients with cauda equina lesions. These differences in inclusion criteria are likely to impact on the expected outcomes for interventions used in people with MESCC in clinical settings. </p> </section> <section id="CD006716-sec-0149"> <h5 class="title">Differences in the definition of ambulation</h5> <p>Although ambulation was the primary outcome in all seven trials, there were differences in the definition of ambulation. <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> reported a participant as ambulant if he or she was able to take at least two steps with each foot (four steps in total) either unassisted or with use of a cane or walker at completion of radiotherapy. In <a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> and <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>, participants who were walking with or without support at one month were considered ambulant, but this was not quantified. The three corticosteroid studies measured ambulation at different time points and in different ways. It is important that ambulation be defined in a manner that is uniform, meaningful and worthwhile, for patients considering the intervention. </p> </section> <section id="CD006716-sec-0150"> <h5 class="title">Surgical decompression versus external radiotherapy</h5> <p>The assertion by <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> that, "However, the results of our trial do not lend support to the use of radiation alone as first‐line treatment"; and the concluding remarks, "..the best treatment for spinal cord compression caused by metastatic cancer is surgery as initial treatment followed by radiotherapy," are important to address from a clinical decision‐making perspective. A cost effectiveness analysis from this group also supported this assertion (<a href="./references#CD006716-bbs2-0065" title="ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy vs. radiotherapy alone for treatment of metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66:1212‐8. ">Thomas 1996</a>). Another cost‐utility analysis suggested that adopting surgery plus RT as standard for patients with MSCC would result in improved outcome but would increase health care costs (<a href="./references#CD006716-bbs2-0027" title="FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology 20122012;14(5):631‐40. ">Furlan 2012</a>). </p> <p>There are a number of reasons why surgery may not uniformly offer the best option as first line treatment in people with MESCC. They include the potential selection bias favouring better outcomes with decompressive surgery in <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>; the applicability of the results of this trial to resource‐constrained settings; and the potential biases arising from the premature termination of the trial. The overall quality of the evidence for ambulatory and survival outcomes for which comparative data were available was rated as of <i>low quality (</i><a href="./full#CD006716-tbl-0004">summary of findings Table 4</a><i>).</i> </p> <p>One reason for our lack of confidence in the reported effect estimates translating to real world settings was the bias in the trial in the selection of participants. <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> selected patients who were good candidates for surgery and excluded participants who were good candidates for radiotherapy (those with radiosensitive tumours). Most common carcinomas in adults are (moderately) radiosensitive. Radio‐resistant tumours like melanomas and osteogenic/soft tissue sarcomas are uncommon. Some highly radio‐sensitive tumours such as hematologic, round cell or germ cell tumours are generally treated with chemotherapy. However, as also noted by <a href="./references#CD006716-bbs2-0064" title="SciubbaDM , PetteysRJ , DekutoskiMB , FisherCG , FehlingsMG , OndraSL , et al. Diagnosis and management of metastatic spine disease. A review. Journal of Neurosurgery. Spine2010;13(1):94‐108. ">Sciubba 2010</a>, other radiosensitive tumours such as small cell lung carcinoma were excluded from both RT and surgical groups in <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>. Moreover, 18/51 patients (35%) given RT had unstable spines, precluding them from being mobilised early; and the secondary effects of non‐ambulation were significantly associated with 30‐day morbidity and mortality (due to infections and deep vein thrombosis etc) in the trial. Only 45% of those treated with RT maintained or regained ambulation compared to 75% treated with surgery and RT. This contrasts with the 66% to 70% ambulatory rates seen in clinical practice (<a href="./references#CD006716-bbs2-0047" title="MaranzanoE , TrippaF . Be careful in getting cost effectiveness conclusions from a debatable trial. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314. ">Maranzano 2007</a>; <a href="./references#CD006716-bbs2-0055" title="RadesD , DouglasS , VeningaT , StalpersLJ , HoskinPJ , BajrovicA , et al. Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer2010;116(15):3670‐3. ">Rades 2010a</a>; <a href="./references#CD006716-bbs2-0058" title="RadesD , HuttenlocherS , BajrovicA , KarstensJH , AdamietzIA , KazicN , et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. International Journal of Radiation Oncology, Biology, Physics2011;81(5):e861‐8. ">Rades 2011b</a>), and in trials after RT alone (<a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a>; <a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a>). <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> did not provide the results in patients with unstable spines treated with radiotherapy alone, but unstable spines were a predictor for poor outcome in the study population as a whole. Twenty per cent of ambulant patients randomised to the radiotherapy arm crossed over to surgery on the occurrence of neurological deterioration and lost the ability to walk. Thirty per cent of them regained the ability to walk, but the complication rate was higher in this group. <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> therefore justified the use of surgery as the first line of therapy even in ambulant patients. However, the selection criteria appear to have biased the results in <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> against radiotherapy. It also took 10 years in <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> to recruit 50% of their estimated sample size, adding support to the contention that those selected for this trial represent only a fraction (probably around 15%) of those with MESCC seen in clinical practice, and do not represent the usual candidates given RT for MESCC (<a href="./references#CD006716-bbs2-0047" title="MaranzanoE , TrippaF . Be careful in getting cost effectiveness conclusions from a debatable trial. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314. ">Maranzano 2007</a>; <a href="./references#CD006716-bbs2-0056" title="RadesD , HuttenlocherS , DunstJ , BajrovicA , KarstensJH , RudatV , et al. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. Journal of Clinical Oncology2010;28(22):3597‐604. ">Rades 2010b</a>; <a href="./references#CD006716-bbs2-0058" title="RadesD , HuttenlocherS , BajrovicA , KarstensJH , AdamietzIA , KazicN , et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. International Journal of Radiation Oncology, Biology, Physics2011;81(5):e861‐8. ">Rades 2011b</a>), since radiotherapy does not relieve compressions caused by bone fragments; nor does it correct deformities such as vertebral collapse (<a href="./references#CD006716-bbs2-0072" title="WiseJJ , FischgrundJS , HerkowitzHN , MontgomeryD , KurzLT . Complication, survival rates, and risk factors of surgery for metastatic disease of the spine. Spine1999;24(18):1943‐51. ">Wise 1999</a>; <a href="./references#CD006716-bbs2-0039" title="KlimoP , ThompsonCJ , KestleJRW , SchmidtMHS . A meta‐analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro‐oncology2005;7(1):64‐76. ">Klimo 2005</a>). </p> <p>The secondary analysis of data from <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> revealed that patients over 65 years of age did not benefit from surgery, compared to younger patients, for ambulation or survival (<a href="./references#CD006716-bbs2-0021" title="ChiJH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?: results from a randomized clinical trial. Spine (Phila Pa 1976).2009;34(5):431‐5. ">Chi 2009</a>). This observation was supported by the matched‐pair analysis in <a href="./references#CD006716-bbs2-0059" title="RadesD , HuttenlocherS , EversJN , BajrovicA , KarstensJH , RudatV , et al. Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?. Strahlentherapie und Onkologie2012;188(5):424‐30. ">Rades 2012</a>. In two other retrospective matched‐pair analyses from Europe that currently constitute the largest available database of malignant spinal cord compression, <a href="./references#CD006716-bbs2-0056" title="RadesD , HuttenlocherS , DunstJ , BajrovicA , KarstensJH , RudatV , et al. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. Journal of Clinical Oncology2010;28(22):3597‐604. ">Rades 2010b</a> first demonstrated in 324 patients with MESCC from a variety of tumour types, who were matched on 11 prognostic variables, that surgery (decompressive surgery plus vertebral stabilisation and laminectomy) followed by RT did not significantly differ from RT alone in the proportions who maintained or regained ambulation; or for local control, or survival. <a href="./references#CD006716-bbs2-0058" title="RadesD , HuttenlocherS , BajrovicA , KarstensJH , AdamietzIA , KazicN , et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. International Journal of Radiation Oncology, Biology, Physics2011;81(5):e861‐8. ">Rades 2011b</a> further evaluated outcomes with surgery followed by RT (N = 67) and RT alone (N = 134) in a retrospective matched‐pair analysis of people with MESCC with an unfavourable primary tumour (non‐small cell lung cancers, cancer of unknown primary, renal cell carcinoma and colorectal cancer), and concluded that decompressive surgery plus RT (but not laminectomy) improved ambulation compared to RT alone, especially if the interval between surgery and RT did not exceed two weeks. These observations add to the body of evidence indicating that decompressive surgery followed immediately by radiotherapy primarily benefits people with MESCC with poor prognostic factors for RT. Both studies called for further adequately powered definitive RCTs to evaluate the role of surgical decompression in people with MESCC representative of those usually seen in clinical practice (<a href="./references#CD006716-bbs2-0056" title="RadesD , HuttenlocherS , DunstJ , BajrovicA , KarstensJH , RudatV , et al. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. Journal of Clinical Oncology2010;28(22):3597‐604. ">Rades 2010b</a>; <a href="./references#CD006716-bbs2-0058" title="RadesD , HuttenlocherS , BajrovicA , KarstensJH , AdamietzIA , KazicN , et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. International Journal of Radiation Oncology, Biology, Physics2011;81(5):e861‐8. ">Rades 2011b</a>). </p> <p>In <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>, emergency surgery was offered within 24 hours of the diagnosis of cord compression and within 48 hours of onset of paraplegia and within two weeks of the onset of symptoms in the majority. RT was also offered as an emergency treatment. These may not be feasible for all people with MESCC in many healthcare settings outside a clinical trial, and particularly in resource‐poor settings. The effect estimates in <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> are therefore not likely to reflect the effects achievable in practice in many parts of the world, if surgery were to be routinely offered as first‐line treatment for people with MESCC. The results of the <a href="./references#CD006716-bbs2-0058" title="RadesD , HuttenlocherS , BajrovicA , KarstensJH , AdamietzIA , KazicN , et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. International Journal of Radiation Oncology, Biology, Physics2011;81(5):e861‐8. ">Rades 2011b</a> matched‐pair analysis of people with unfavourable primaries indicate that optimal outcomes with decompressive surgery also depend on RT being given within two weeks of decompressive surgery, as was done in <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>. Delays in offering RT within this time period may also occur in different parts of the world, due to resource constraints, delays in referral, and due to post‐operative complications (as was seen in 53% of 17 patients with RT delayed beyond two weeks after surgery in <a href="./references#CD006716-bbs2-0058" title="RadesD , HuttenlocherS , BajrovicA , KarstensJH , AdamietzIA , KazicN , et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. International Journal of Radiation Oncology, Biology, Physics2011;81(5):e861‐8. ">Rades 2011b</a>). </p> <p>Another reason that limited our confidence in the results of <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> was that this trial was stopped early for apparent benefit after recruiting only 50% of the estimated sample. Truncated RCTs are at high risk of over‐estimating benefits (<a href="./references#CD006716-bbs2-0030" title="GuyattGH , BrielM , GlasziouP , BasslerD , MontoriV . Problems of stopping trials early. BMJ2012;344:e3863. ">Guyatt 2012</a>), particularly when the total number of events are less than 500, and even more so when events number less than 200 (<a href="./references#CD006716-bbs2-0020" title="BasslerD , BrielM , MontoriVM , LaneM , GlasziouP , ZhouQ , et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta‐regression analysis. JAMA2010;303(12):1180‐7. ">Bassler 2010</a>). The evidence in favour of surgery as a potential first‐line treatment in MESCC comes from only one RCT with 101 participants. It is also likely that the premature termination of this trial due to apparent benefit prevented the conduct of more definitive trials, since it would have been considered unethical to do so (<a href="./references#CD006716-bbs2-0030" title="GuyattGH , BrielM , GlasziouP , BasslerD , MontoriV . Problems of stopping trials early. BMJ2012;344:e3863. ">Guyatt 2012</a>). </p> <p>Finally, circumferential decompression or combined (anterior, posterior, and lateral) approaches are only feasible in healthier patients and are not feasible for the majority of patients with MESCC who often have numerous comorbid conditions precluding such aggressive interventions (<a href="./references#CD006716-bbs2-0049" title="MolinaCA , GokaslanZL , SciubbaDM . A systematic review of the current role of minimally invasive spine surgery in the management of metastatic spine disease. International Journal of Surgical Oncology2011;2011:598148. [DOI: 10.1155/2011/598148] ">Molina 2011</a>). </p> <p>Current evidence suggests that decompressive surgery with external fixation, if needed, is indicated in people (younger than 65 years) with MESC who are expected to live for three months or more, are medically fit for surgery, have spinal instability or bony impingement and a recent onset of paraplegia; or who have tumours not sensitive to radiation; and particularly when RT can be offered within two weeks of surgery. Evidence of moderate or high quality is currently lacking to recommend the routine use of decompressive surgery for all people with MESCC. The optimal dose, schedules and duration of post‐operative RT are currently unclear. </p> </section> </section> </section> <section id="CD006716-sec-0151"> <h3 class="title" id="CD006716-sec-0151">Quality of the evidence</h3> <p>We assessed the overall quality of the evidence using the GRADE approach (<a href="./references#CD006716-bbs2-0063" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results drawing conclusions. Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. ">Schünemann 2011</a>), that considers ‘quality’ to be a judgement of the extent to which we can be confident that the estimates of effect are correct. Evidence from randomised controlled studies is initially graded as high and downgraded by one or two levels on each of five domains after full consideration of: limitations in the design of the studies, the directness (or applicability) of the evidence, the consistency and precision of the results, and the possibility of publication bias. A GRADE quality level of <i>'high'</i> reflects confidence that the true effect lies close to that of the estimate of the effect for an outcome. A judgement of <i>'moderate'</i> quality indicates that the true effect is likely to be close to the estimate of the effect, but acknowledges the possibility that it could be substantially different, and that future research could alter the effect estimates. <i>Low</i> and <i>very low</i> quality evidence limit our confidence in the effect estimates, and indicates that future research is likely to alter the effect estimates and our confidence in the estimates (<a href="./references#CD006716-bbs2-0019" title="BalshemH ,  HelfandM ,  SchünemannHJ ,  OxmanAD ,  KunzR ,  BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401‐6. ">Balshem 2011</a>). </p> <p>The evidence for key outcomes in the comparisons of different radiotherapy regimens was rated as <i>moderate</i> quality (<a href="./full#CD006716-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD006716-tbl-0002">summary of findings Table 2</a>) with the factor limiting full confidence being that each comparison was represented by only one trial conducted in a high‐income setting. The evidence for most outcomes for the surgical intervention trials was rated as <i>low</i> or<i>very low</i> quality (<a href="./full#CD006716-tbl-0003">summary of findings Table 3</a>; <a href="./full#CD006716-tbl-0004">summary of findings Table 4</a>), with indirectness and imprecision being reasons for limiting full confidence in the effect estimates. The evidence for most outcomes for the steroid comparisons were rated as <i>low</i> quality due to imprecision in effect estimates resulting from the small numbers evaluated, though we had greater confidence in estimates indicating an increased risk of adverse events with high dose steroids (<i>moderate quality evidence;</i><a href="./full#CD006716-tbl-0005">summary of findings Table 5</a>). </p> </section> <section id="CD006716-sec-0152"> <h3 class="title" id="CD006716-sec-0152">Potential biases in the review process</h3> <p>We used standard methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006716-bbs2-0035" title="HigginsJPT , DeeksJJ , AltmanDG . Chapter 16: Special topics in statistics. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011b</a>), and also ensured compliance with the Cochrane standards for the conduct of reviews of interventions (<a href="./references#CD006716-bbs2-0048" title="ChandlerJ , ChurchillR , HigginsJ , LassersonT , ToveyD . Methodological Expectations of Cochrane Intervention Reviews (MECIR). Methodological standards for the conduct of new Cochrane Intervention Reviews. Version 2.1, 8 December 2011. Available at: http://www.editorial‐unit.cochrane.org/sites/editorial‐unit.cochrane.org/files/uploads/MECIR_conduct_standards%202.1.pdf (accessed on 27 March 2012). ">MECIR 2011</a>). These should have minimised biases in the review process. </p> </section> <section id="CD006716-sec-0153"> <h3 class="title" id="CD006716-sec-0153">Agreements and disagreements with other studies or reviews</h3> <p>The findings in this review are in concordance with current guidance for the treatment of MESCC and with more recent reviews on this topic (<a href="./references#CD006716-bbs2-0050" title="National Institute for Clinical Excellence (NICE). CG 75 Metastatic spinal cord compression. Available at: http://guidance.nice.org.uk/CG75/NICEGuidance/pdf 2008 (accessed 10 December 2013). ">NICE 2008</a>; <a href="./references#CD006716-bbs2-0064" title="SciubbaDM , PetteysRJ , DekutoskiMB , FisherCG , FehlingsMG , OndraSL , et al. Diagnosis and management of metastatic spine disease. A review. Journal of Neurosurgery. Spine2010;13(1):94‐108. ">Sciubba 2010</a>; <a href="./references#CD006716-bbs2-0036" title="HoltT , HoskinP , MaranzanoE , SahgalA , SchildSE , RyuS , et al. Malignant epidural spinal cord compression: the role of external beam radiotherapy. Current Opinion in Supportive and Palliative Care2012;6(1):103‐8. ">Holt 2012</a>; <a href="./references#CD006716-bbs2-0037" title="KimJM , LosinaE , BonoCM , SchoenfeldAJ , CollinsJE , KatzJN , et al. Clinical outcome of metastatic spinal cord compression treated with surgical excision ± radiation versus radiation therapy alone: a systematic review of literature. Spine (Philadelphia, Pa.: 1976)2012;37(1):78‐84. ">Kim 2012</a>; <a href="./references#CD006716-bbs2-0044" title="LoblawDA , MiteraG , FordM , LaperriereNJ . A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2012;84(2):312‐7. ">Loblaw 2012</a>; <a href="./references#CD006716-bbs2-0045" title="L'espéranceS , VincentF , GaudreaultM , OuelletJA , LiM , TosikyanA , GouletS , Comité de l’évolution des pratiques enoncologie . Treatment of metastatic spinal cord compression: cepo review and clinical recommendations.. Current Oncology2012;19(6):e478‐90. ">L’espérance 2012</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006716-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/urn:x-wiley:14651858:media:CD006716:CD006716-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_t/tCD006716-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow diagram depicting study selection" data-id="CD006716-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA flow diagram depicting study selection</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006716-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/urn:x-wiley:14651858:media:CD006716:CD006716-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_t/tCD006716-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006716-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006716-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/urn:x-wiley:14651858:media:CD006716:CD006716-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_t/tCD006716-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006716-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006716-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/urn:x-wiley:14651858:media:CD006716:CD006716-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_t/tCD006716-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 High dose versus no or moderate dose corticosteroids, outcome: 1.2 Serious drug related adverse effects." data-id="CD006716-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 High dose versus no or moderate dose corticosteroids, outcome: 1.2 Serious drug related adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006716-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/urn:x-wiley:14651858:media:CD006716:CD006716-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_t/tCD006716-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 High dose versus no or moderate dose corticosteroids, Outcome 1 Overall ambulation (short term)." data-id="CD006716-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 High dose versus no or moderate dose corticosteroids, Outcome 1 Overall ambulation (short term). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/references#CD006716-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006716-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/urn:x-wiley:14651858:media:CD006716:CD006716-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_t/tCD006716-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 High dose versus no or moderate dose corticosteroids, Outcome 2 Serious drug related adverse effects." data-id="CD006716-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 High dose versus no or moderate dose corticosteroids, Outcome 2 Serious drug related adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/references#CD006716-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/media/CDSR/CD006716/image_n/nCD006716-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006716-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Single‐fraction radiotherapy (8 Gy) compared to short‐course radiotherapy (16 Gy in two fractions) for adults with metastatic extradural spinal cord compression</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Single‐fraction radiotherapy (8 Gy) compared to short‐course radiotherapy (8 Gy ‐ two fractions over one week) for adults with metastatic extradural spinal cord compression</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with metastatic extradural spinal cord compression (poor prognosis with visceral metastasis, and no spinal instability or bony impingement of cord)<br/> <b>Intervention:</b> single‐fraction (8 Gy) radiotherapy<br/> <b>Comparison:</b> short‐course (8 Gy ‐ two fractions over one week) radiotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Short‐course radiotherapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Single‐fraction radiotherapy </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ambulation</b> </p> <p>One month after radiation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>693 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>645 per 1000</b><br/> (569 to 721) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.93</b> <br/> (0.82 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303<br/> (1 study<sup>1</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single‐fraction and short‐course radiotherapy are probably equally effective in enhancing ambulation (maintaining and regaining ambulation) in the short term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival</b><br/> Follow‐up: mean 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median survival was similar with both radiotherapy schedules (four months).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in analgesic and narcotic use</b> </p> <p>One month after radiation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>403 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>343 per 1000</b><br/> (250 to 467) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.85</b> <br/> (0.62 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>271<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single‐fraction and short‐course radiotherapy are probably equally effective in reducing analgesic and narcotic use in the short term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary continence</b> </p> <p>One month after radiation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>873 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>900 per 1000</b><br/> (838 to 961) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.03</b> <br/> (0.96 to 1.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single‐fraction and short‐course radiotherapy are probably equally effective in enhancing urinary continence overall, and in the proportions maintaining or regaining continence one month after treatment. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Local recurrence</b><br/> MRI: follow‐up: median 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>59 per 1000</b><br/> (18 to 187) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.21</b> <br/> (0.69 to 7.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,4</sup> </p> <p>(serious indirectness, serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Short‐course radiotherapy may result in fewer local recurrences than single fraction radiotherapy, but the numbers with local recurrences were too few for the difference to be statistically significant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b><br/> Grade 3 oesophagitis, diarrhoea and nausea </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>3 per 1000</b><br/> (0 to 54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.14</b> <br/> (0.01 to 2.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>303<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single‐fraction and short‐course radiotherapy probably do not differ significantly in the incidence of gastrointestinal adverse effects. Serious adverse events or post‐radiotherapy myelopathy were not noted with either treatment schedule. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup><a href="./references#CD006716-bbs2-0003" title="MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. MaranzanoE , TrippaF , CasaleM , CostantiniS , LupattelliM , BellavitaR , et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology2009;93(2):174‐9. ">Maranzano 2009</a> was conducted in multiple sites in Italy and used an equivalence design with the sample size powered to demonstrate equivalence in response rates separately evaluated for ambulatory status (maintaining or regaining ambulation), urinary continence (not requiring a catheter), and reduction in back pain (not requiring a narcotic) one month after treatment. Parenteral dexamethasone (8 mg twice daily) was administered from the first day of clinical‐radiologic diagnosis for 4–5 days.<br/> <sup>2</sup> Serious indirectness: the trial included those usually given short‐course radiotherapy (those with poor prognosis, with visceral metastasis, and not suitable for surgery). However the evidence for the equivalence of single dose and short‐course radiotherapy is from only one trial from a high‐income country, where early diagnosis and early institution of radiotherapy (within 24 to 48 hours after diagnosis) was possible; these may not be possible in many resource constrained settings. Downgraded 1 level.<br/> <sup>3</sup> No imprecision: the trial was powered to demonstrate equivalence in response rates post‐treatment and the difference in response rates with the two radiotherapy schedules was within the pre‐set precision limits. Not downgraded.<br/> <sup>4</sup> Serious imprecision: the trial was not powered to detect equivalence for this outcome; the 95% CI of the effect estimate includes no difference. The number of events were few and the sample size was smaller than the optimal sample size. Downgraded 1 level. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Single‐fraction radiotherapy (8 Gy) compared to short‐course radiotherapy (16 Gy in two fractions) for adults with metastatic extradural spinal cord compression</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006716-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Split‐course radiotherapy (8 fractions, 30 Gy) compared to short‐course radiotherapy (2 fractions, 16 Gy) for adults with metastatic extradural spinal cord compression</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Split‐course (8 fractions, 30 Gy) radiotherapy compared to short‐course (2 fractions, 16 Gy) radiotherapy for adults with metastatic extradural spinal cord compression</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with metastatic extradural spinal cord compression (poor prognosis, no spinal instability or bony impingement of cord)<br/> <b>Intervention:</b> split‐course radiotherapy (8 fractions‐ 5 Gy × 3; 3 Gy × 5 = 30 Gy)<br/> <b>Comparison:</b> short‐course radiotherapy (2 fractions × 8 Gy = 16 Gy) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Short‐course radiotherapy (2 fractions)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Split‐course radiotherapy (8 fractions)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ambulation</b> <br/> One month after treatment </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>683 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>697 per 1000</b><br/> (615 to 786) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.02</b> <br/> (0.9 to 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>276<br/> (1 study<sup>1</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Split‐course and short‐course radiotherapy are probably equally effective in enhancing ambulation (maintaining and regaining ambulation) in the short term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival</b><br/> Follow‐up: median 33 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median survival was similar with both treatment schedules (four months).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in analgesic and narcotic use</b> </p> <p>One month after radiation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>382 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>486 per 1000</b><br/> (367 to 639) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.27</b> <br/> (0.96 to 1.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>262<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Split‐course and short‐course radiotherapy are probably equally effective in reducing analgesic and narcotic use in the short term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary continence</b> </p> <p>One month after radiation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>901 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>874 per 1000</b><br/> (838 to 919) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> <br/> (0.93 to 1.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>275<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2,3</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Split‐course and short‐course radiotherapy are probably equally effective in enhancing urinary continence overall, and in the proportions maintaining or regaining continence one month after treatment. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Local recurrence</b><br/> Follow‐up: median 33 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>35 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>4 per 1000</b><br/> (0 to 61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.1</b> <br/> (0.01 to 1.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>276<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,4</sup> </p> <p>(serious indirectness, serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Split‐course radiotherapy probably results in fewer local recurrences than short‐course radiotherapy, but the numbers with local recurrences were too few to demonstrate statistically significant differences. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b><br/> Grade 3 oesophagitis, diarrhoea, and nausea </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>21 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b><br/> (9 to 153) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.77</b> <br/> (0.43 to 7.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>276<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4</sup> </p> <p>(serious indirectness)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Split‐course and short‐course radiotherapy probably do not differ significantly in the incidence of gastrointestinal adverse effects. Serious adverse events or post‐radiotherapy myelopathy were not noted with either treatment schedule. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup><a href="./references#CD006716-bbs2-0002" title="KwokY , PatchellRA , RegineWF . Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. KwokY , RegineWF , PatchellRA . Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology2005;23(15):3308‐10. MacbethF , StephensR , HoskinP . Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology2005;23(32):8270. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology2005; Vol. 23, issue 32:8270‐2. MaranzanoE , BellavitaR , RossiR , DeAngelisV , FrattegianiA , BagnoliR , et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology2005;23(15):3358‐65. MaranzanoE , TrippaF , CasaleM , AnselmoP , RossiR . Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology2011;98(2):234‐7. ">Maranzano 2005</a> was conducted in multiple sites in Italy and used an equivalence design with the sample size powered to demonstrate equivalence in response rates separately evaluated for ambulatory status (maintaining or regaining ambulation), urinary continence (not requiring a catheter), and reduction in back pain (not requiring a narcotic) one month after treatment.. Dexamethasone: 8 mg twice daily was given to both arms and tapered after completion of radiotherapy.<br/> <sup>2</sup> Serious indirectness: the trial included those usually given short courses of radiotherapy (patients with poor prognosis; no spinal instability or bony impingement causing cord compression). However this trial is from a high‐income country where early diagnosis and early institution of radiotherapy (within 24 hours after diagnosis) was possible; these may not be possible in many low‐ and middle‐income settings. Downgraded 1 level.<br/> <sup>3</sup> No imprecision: the trial was powered to demonstrate equivalence in response rates post‐treatment and the difference in response rates with the two radiotherapy schedules was within the pre‐set precision limits. Not downgraded.<br/> <sup>4</sup> Serious imprecision: the trial was not powered to detect equivalence for this outcome.. The number of events were few, and the 95% CI of the risk difference indicated non‐appreciable benefits with both schedules. The sample size was smaller than the optimal sample size. Downgraded 1 level. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Split‐course radiotherapy (8 fractions, 30 Gy) compared to short‐course radiotherapy (2 fractions, 16 Gy) for adults with metastatic extradural spinal cord compression</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006716-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Laminectomy plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Laminectomy plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with metastatic extradural spinal cord compression (single lesion, no prior radiotherapy, fit for surgery)<br/> <b>Intervention:</b> laminectomy plus radiotherapy<br/> <b>Comparison:</b> radiotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Radiotherapy </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Laminectomy plus radiotherapy </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ambulation</b> </p> <p>At four months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>385 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>373 per 1000</b><br/> (146 to 954) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.98</b> <br/> (0.38 to 2.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study<sup>1</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4</sup> </p> <p>(risk of bias, serious indirectness, very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laminectomy followed by radiotherapy may offer no advantage over radiotherapy alone in enhancing ambulation. . </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival</b> </p> <p>At four months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>462 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>563 per 1000</b><br/> (272 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.22</b> <br/> (0.59 to 2.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> <p>(serious indirectness, very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laminectomy followed by radiotherapy may offer no advantage over radiotherapy alone in improving survival. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in analgesic use</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>440 per 1000</b><br/> (210 to 905) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.88</b> <br/> (0.42 to 1.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>26<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> <p>(serious indirectness, very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laminectomy followed by radiotherapy may offer no advantage over radiotherapy alone in reducing analgesic use. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary continence</b> </p> <p>One month after treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>538 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>32 more per 1000</b><br/> (232 fewer to 538 more) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.06</b> <br/> (0.57 to 2.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2,3,4</sup> </p> <p>(risk of bias, serious indirectness, very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laminectomy followed by radiotherapy may offer no advantage over radiotherapy alone in enhancing urinary continence. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Local recurrence</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No adverse events were reported with laminectomy plus RT or with RT, but it is unclear if these were systematically ascertained </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessed</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Data from <a href="./references#CD006716-bbs2-0007" title="YoungRF , PostEM , KingGA . Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery1980;53:741‐8. ">Young 1980</a>: radiotherapy was given as 30 Gy in 10 fractions (4 Gy/day first 3 days, then 18 Gy in 7 fractions over 14 days), Both arms were given dexamethasone 12 mg; followed by 4 mg four times daily till radiotherapy completion. </p> <p><sup>2</sup> Serious risk of bias. There were baseline imbalances in the proportions with myelographic block and this negatively influenced effect estimates for the outcomes of ambulation and urinary continence. Downgraded 1 level.<br/> <sup>3</sup> Serious indirectness: the trial included those likely to be offered a surgical intervention in preference to radiotherapy. However, the data for the comparative effects of laminectomy versus radiotherapy come from only one small trial done over 30 years ago. Downgraded 1 level.<br/> <sup>4</sup> Very serious imprecision. The 95% CI of the effect estimate indicates appreciable benefits for both interventions. The number of events and participants were too few to provide reliable estimates. Downgraded by 2 levels. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Laminectomy plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006716-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Decompressive surgery plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Decompressive surgery plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with metastatic extradural spinal cord compression (fit for surgery, paraplegic less than 48 hours, and without multiple discrete compressions or radiosensitive tumours; with cervical or thoracic lesions, and life expectancy three months or more)<br/> <b>Intervention:</b> decompressive surgery plus radiotherapy<br/> <b>Comparison:</b> radiotherapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Radiotherapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Decompressive surgery plus radiotherapy </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ambulation</b> </p> <p>Immediately after completing RT</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>569 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>842 per 1000</b><br/> (660 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.48</b> <br/> (1.16 to 1.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101<br/> (1 study<sup>1</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> <p>(serious indirectness, serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery plus RT may be superior to RT in enhancing ambulation (maintaining ambulation: and regaining ambulation) in selected patients with MESCC </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival (short term)</b> </p> <p>At 30 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>863 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>940 per 1000</b><br/> (828 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.09</b> <br/> (0.96 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> <p>(serious indirectness, serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery plus RT may not significantly enhance proportions surviving compared to RT (though median survival may be longer with surgery plus RT: 126 days versus 100 days). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in analgesic and narcotic use</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery plus RT may have beneficial effects compared to RT in reducing analgesic use (median daily morphine equivalent dose: 0·4 mg (0 to 60 mg) versus 4·8 mg (0 to 200 mg; P = 0·002). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary continence</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery plus RT may have beneficial effects compared to RT in enhancing the maintenance of urinary continence (median duration for maintenance of continence: 156 days versus 17 days; P = 0.016)<sup>4</sup>. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Local recurrence</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>101</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events were seen after surgery or after RT. In 10 participants randomised to RT who subsequently had surgery, 4 (40%) had surgical complications (wound infections‐3; failure of fixation‐1). Other adverse events were not reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the risk in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Data from <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a>: surgery ‐ direct circumferential decompression with or without stabilisation within 24 hours of randomisation; Radiotherapy‐ 3 Gy x 10, starting within 24 hours after randomisation (in most), or within 14 days of surgery. All patients were given 100 mg dexamethasone immediately at diagnosis, then 24 mg every 6 hours until the start of radiotherapy or surgery, after which steroids were then reduced and continued until completion of radiotherapy.<br/> <sup>2</sup> Serious indirectness: this trial selected patients who were good candidates for surgery and excluded participants with radiosensitive tumours; 18 patients given RT had unstable spines. These biased the results against radiotherapy and the participants given RT were not representative of the usual candidates for RT. Emergency surgery was offered within 24 hours of the diagnosis of cord compression, within 48 hours of onset of paraplegia and within two weeks of the onset of symptoms in most. RT was also offered as an emergency. These may not be feasible outside a clinical trial setting and in healthcare systems in resource poor countries. Downgraded 1 level.<br/> <sup>3</sup> Serious imprecision. This trial was stopped early for apparent benefit after recruiting only 50% of the estimates sample. Truncated RCTs are at risk of over‐estimating benefits (<a href="./references#CD006716-bbs2-0020" title="BasslerD , BrielM , MontoriVM , LaneM , GlasziouP , ZhouQ , et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta‐regression analysis. JAMA2010;303(12):1180‐7. ">Bassler 2010</a>). The evidence in favour of surgery comes from only one trial with 101 participants, and the sample size is smaller than the optimal information size. Downgraded 1 level. </p> <p><sup>4</sup> Based on secondary analysis in the <a href="./references#CD006716-bbs2-0004" title="ChiGH , GokaslanZ , McCormickP , TibbsPA , KryscioRJ , PatchellRA . Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976)2009;34(5):431‐5. FurlanJC , ChanKK , SandovalGA , LamKC , KlingerCA , PatchellRA , et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology2012;14(5):631‐40. FurlanJC , ChanKKW , SandovalG , LamKC , KlingerCA , PatchellRA , et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12. KochM , DeKeyserJ . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. KunklerI . Surgical resection in metastatic spinal cord compression. Lancet2006; Vol. 367, issue 9505:109. MaranzanoE , BellavitaR , RossiR . Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Comment on Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005]. Journal of Clinical Oncology2005;23(32):8270‐2; author reply 8272‐4. MaranzanoE , TrippaF . Be careful in getting cost‐effectiveness conclusions from a debatable trial! Comment on Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. [International Journal of Radiation Oncology, Biology, Physics, 2006]. International Journal of Radiation Oncology, Biology, Physics2007;68(1):314; author reply 314‐5. PatchellR , TibbsPA , RegineF , PayneR , SarisS , KryscioRJ , et al. A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis. Journal of Clinical Oncology2003;21:237S. PatchellRA , TibbsPA , RegineWF , PayneR , SarisS , KryscioRJ , et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet2005;366(9486):643‐8. ThomasKC , NosykB , FisherCG , DvorakM , PatchellRA , RegineWF , et al. Cost‐effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics2006;66(4):1212‐8. van denBentMJ . Surgical resection improves outcome in metastatic epidural spinal cord compression [comment on: Lancet 2005;366(9486):643‐8]. Lancet2005;366(9486):609‐10. ">Patchell 2005</a> report using a Cox model with all covariates included </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Decompressive surgery plus radiotherapy compared to radiotherapy for adults with metastatic extradural spinal cord compression</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006716-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">High‐dose corticosteroids compared to moderate‐dose or no corticosteroids for adults with metastatic extradural spinal cord compression</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>High‐dose corticosteroids compared to moderate‐dose or no corticosteroids for adults with metastatic extradural spinal cord compression</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> adults with metastatic extradural spinal cord compression (without peptic ulceration or infection; mixed prognosis)<br/> <b>Intervention:</b> high‐dose corticosteroids (96 mg and 100 mg bolus)<br/> <b>Comparison:</b> moderate‐dose (10 mg and 16 mg) or no corticosteroids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Moderate‐dose or no corticosteroids</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>High dose corticosteroids</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ambulation</b> </p> <p>Follow‐up: one week to three months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>550 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>594 per 1000</b><br/> (446 to 798) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.08</b> <br/> (0.81 to 1.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105<br/> (3 studies<sup>1</sup>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> <p>(very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High dose steroids may not offer any beneficial effects compared to moderate dose steroids in enhancing ambulation. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Survival (long term)</b> </p> <p>Over two years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>111 per 1000</b><br/> (25 to 505) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.11</b> <br/> (0.24 to 5.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> <p>(very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High dose steroids may offer no beneficial effects compared to no steroids in enhancing long term survival. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain reduction</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>909 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>782 per 1000</b><br/> (564 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.86</b> <br/> (0.62 to 1.20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3</sup> </p> <p>(very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High dose steroids may offer no beneficial effects compared to moderate dose steroids in reducing pain. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Urinary continence</b> </p> <p>One week after treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>533 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>629 per 1000</b><br/> (352 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.18</b> <br/> (0.66 to 2.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2</sup> </p> <p>(very serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High dose steroids may offer no beneficial effects compared to moderate dose steroids in enhancing urinary continence. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Local recurrence</b> ‐ </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serious adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 8.02</b> <br/> (1.03 to 62.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> <p>(serious imprecision)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious adverse events (such as perforated gastric ulcer, psychoses and deaths due to infection) occurred only with high dose steroids: 6/36 (17%) versus 0/41 (0%) on moderate dose (N = 11) or no steroids (N = 30). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across studies for pooled data or the control group risk in single studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup><a href="./references#CD006716-bbs2-0006" title="VechtCJ , Haaxma‐ReicheH , vanPuttenWL , deVisserM , VriesEP , TwijnstraA . Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology1989;39(9):1255‐7. ">Vecht 1989</a> and <a href="./references#CD006716-bbs2-0001" title="GrahamPH , CappA , DelaneyG , GoozeeG , HickeyB , TurnerS , et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol)2006;18(1):70‐6. [NCT00193869] ">Graham 2006</a> compared high dose (100 to 96 mg dexamethazone) versus moderate dose steroids (10 to 16 mg); <a href="./references#CD006716-bbs2-0005" title="SorensenS , Helweg‐LarsenS , MouridsenH , HansenHH . Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer1994;30A(1):22‐7. ">Sorensen 1994</a> compared a single IV dose of 100 mg dexamethazone with saline placebo. The three trials were free of the risk of serious biases for efficacy outcomes.<br/> <sup>2</sup> Very serious imprecision: the 95% CI of the effect estimates indicate appreciable benefit for high dose and moderate dose or no steroids. Downgraded 2 levels. </p> <p><sup>3</sup> Serious imprecision: the 95% CI of the effect estimate indicates appreciable and non‐appreciable benefits with moderate dose or no steroids; and the number of events and participants were too few to provide reliable estimates. Downgraded 1 level. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">High‐dose corticosteroids compared to moderate‐dose or no corticosteroids for adults with metastatic extradural spinal cord compression</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/full#CD006716-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006716-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">High dose versus no or moderate dose corticosteroids</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall ambulation (short term) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.81, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 High dose versus no corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.93, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 High versus moderate corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.46, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serious drug related adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.02 [1.03, 62.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 High dose versus no corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.96 [0.56, 176.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 High dose versus moderate dose corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.0 [0.32, 111.04]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">High dose versus no or moderate dose corticosteroids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006716.pub3/references#CD006716-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006716.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006716-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006716-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD006716-note-0001">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006716-note-0011">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006716\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006716\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006716\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006716\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006716\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ytRBD0EW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006716.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006716.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006716.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006716.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006716.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729451660"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006716.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729451664"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006716.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918edd368ff3bd65',t:'MTc0MDcyOTQ1Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 